<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="en" xml:lang="en"><head>

<meta charset="utf-8">
<meta name="generator" content="quarto-1.8.26">

<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes">


<title>Trends &amp; Insights ‚Äì R/Pharma 2025</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
div.columns{display: flex; gap: min(4vw, 1.5em);}
div.column{flex: auto; overflow-x: auto;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
ul.task-list li input[type="checkbox"] {
  width: 0.8em;
  margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
  vertical-align: middle;
}
/* CSS for syntax highlighting */
html { -webkit-text-size-adjust: 100%; }
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
  { counter-reset: source-line 0; }
pre.numberSource code > span
  { position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
  { content: counter(source-line);
    position: relative; left: -1em; text-align: right; vertical-align: baseline;
    border: none; display: inline-block;
    -webkit-touch-callout: none; -webkit-user-select: none;
    -khtml-user-select: none; -moz-user-select: none;
    -ms-user-select: none; user-select: none;
    padding: 0 4px; width: 4em;
  }
pre.numberSource { margin-left: 3em;  padding-left: 4px; }
div.sourceCode
  {   }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
</style>


<script src="../site_libs/quarto-nav/quarto-nav.js"></script>
<script src="../site_libs/quarto-nav/headroom.min.js"></script>
<script src="../site_libs/clipboard/clipboard.min.js"></script>
<script src="../site_libs/quarto-search/autocomplete.umd.js"></script>
<script src="../site_libs/quarto-search/fuse.min.js"></script>
<script src="../site_libs/quarto-search/quarto-search.js"></script>
<meta name="quarto:offset" content="../">
<script src="../site_libs/quarto-html/quarto.js" type="module"></script>
<script src="../site_libs/quarto-html/tabsets/tabsets.js" type="module"></script>
<script src="../site_libs/quarto-html/axe/axe-check.js" type="module"></script>
<script src="../site_libs/quarto-html/popper.min.js"></script>
<script src="../site_libs/quarto-html/tippy.umd.min.js"></script>
<script src="../site_libs/quarto-html/anchor.min.js"></script>
<link href="../site_libs/quarto-html/tippy.css" rel="stylesheet">
<link href="../site_libs/quarto-html/quarto-syntax-highlighting-587c61ba64f3a5504c4d52d930310e48.css" rel="stylesheet" id="quarto-text-highlighting-styles">
<script src="../site_libs/bootstrap/bootstrap.min.js"></script>
<link href="../site_libs/bootstrap/bootstrap-icons.css" rel="stylesheet">
<link href="../site_libs/bootstrap/bootstrap-7fd3a81f91483ada774992105079aaf8.min.css" rel="stylesheet" append-hash="true" id="quarto-bootstrap" data-mode="light">
<script id="quarto-search-options" type="application/json">{
  "location": "navbar",
  "copy-button": false,
  "collapse-after": 3,
  "panel-placement": "end",
  "type": "overlay",
  "limit": 50,
  "keyboard-shortcut": [
    "f",
    "/",
    "s"
  ],
  "show-item-context": false,
  "language": {
    "search-no-results-text": "No results",
    "search-matching-documents-text": "matching documents",
    "search-copy-link-title": "Copy link to search",
    "search-hide-matches-text": "Hide additional matches",
    "search-more-match-text": "more match in this document",
    "search-more-matches-text": "more matches in this document",
    "search-clear-button-title": "Clear",
    "search-text-placeholder": "",
    "search-detached-cancel-button-title": "Cancel",
    "search-submit-button-title": "Submit",
    "search-label": "Search"
  }
}</script>
<style>html{ scroll-behavior: smooth; }</style>


<link rel="stylesheet" href="../styles.css">
</head>

<body class="nav-fixed quarto-light">

<div id="quarto-search-results"></div>
  <header id="quarto-header" class="headroom fixed-top">
    <nav class="navbar navbar-expand-lg " data-bs-theme="dark">
      <div class="navbar-container container-fluid">
      <div class="navbar-brand-container mx-auto">
    <a class="navbar-brand" href="../index.html">
    <span class="navbar-title">R/Pharma 2025</span>
    </a>
  </div>
            <div id="quarto-search" class="" title="Search"></div>
          <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarCollapse" aria-controls="navbarCollapse" role="menu" aria-expanded="false" aria-label="Toggle navigation" onclick="if (window.quartoToggleHeadroom) { window.quartoToggleHeadroom(); }">
  <span class="navbar-toggler-icon"></span>
</button>
          <div class="collapse navbar-collapse" id="navbarCollapse">
            <ul class="navbar-nav navbar-nav-scroll me-auto">
  <li class="nav-item">
    <a class="nav-link" href="../index.html"> 
<span class="menu-text">Home</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="../workshops/index.html"> 
<span class="menu-text">Workshops</span></a>
  </li>  
  <li class="nav-item">
    <a class="nav-link" href="../presentations/index.html"> 
<span class="menu-text">Presentations</span></a>
  </li>  
  <li class="nav-item dropdown ">
    <a class="nav-link dropdown-toggle" href="#" id="nav-menu-insights" role="link" data-bs-toggle="dropdown" aria-expanded="false">
 <span class="menu-text">Insights</span>
    </a>
    <ul class="dropdown-menu" aria-labelledby="nav-menu-insights">    
        <li>
    <a class="dropdown-item" href="../summary/trends-insights.html">
 <span class="dropdown-text">Trends &amp; Analysis</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../summary/tools-catalog.html">
 <span class="dropdown-text">Tools Catalog</span></a>
  </li>  
        <li>
    <a class="dropdown-item" href="../summary/career-insights.html">
 <span class="dropdown-text">Career Insights</span></a>
  </li>  
    </ul>
  </li>
  <li class="nav-item">
    <a class="nav-link" href="../about.html"> 
<span class="menu-text">About</span></a>
  </li>  
</ul>
            <ul class="navbar-nav navbar-nav-scroll ms-auto">
  <li class="nav-item compact">
    <a class="nav-link" href="https://github.com/ACTN3Bioinformatics/R-Pharma-2025-Workshops"> <i class="bi bi-github" role="img" aria-label="GitHub">
</i> 
<span class="menu-text"></span></a>
  </li>  
</ul>
          </div> <!-- /navcollapse -->
            <div class="quarto-navbar-tools">
</div>
      </div> <!-- /container-fluid -->
    </nav>
</header>
<!-- content -->
<div id="quarto-content" class="quarto-container page-columns page-rows-contents page-layout-article page-navbar">
<!-- sidebar -->
<!-- margin-sidebar -->
    <div id="quarto-margin-sidebar" class="sidebar margin-sidebar">
        <nav id="TOC" role="doc-toc" class="toc-active">
    <h2 id="toc-title">On this page</h2>
   
  <ul>
  <li><a href="#executive-summary" id="toc-executive-summary" class="nav-link active" data-scroll-target="#executive-summary">Executive Summary</a></li>
  <li><a href="#the-aillm-revolution" id="toc-the-aillm-revolution" class="nav-link" data-scroll-target="#the-aillm-revolution">1. The AI/LLM Revolution ü§ñ</a>
  <ul class="collapse">
  <li><a href="#emergence-as-dominant-theme" id="toc-emergence-as-dominant-theme" class="nav-link" data-scroll-target="#emergence-as-dominant-theme">Emergence as Dominant Theme</a></li>
  <li><a href="#from-prototype-to-production" id="toc-from-prototype-to-production" class="nav-link" data-scroll-target="#from-prototype-to-production">From Prototype to Production</a></li>
  <li><a href="#standards-emerging" id="toc-standards-emerging" class="nav-link" data-scroll-target="#standards-emerging">Standards Emerging</a></li>
  <li><a href="#challenges-identified" id="toc-challenges-identified" class="nav-link" data-scroll-target="#challenges-identified">Challenges Identified</a></li>
  </ul></li>
  <li><a href="#open-source-transformation" id="toc-open-source-transformation" class="nav-link" data-scroll-target="#open-source-transformation">2. Open-Source Transformation üåê</a>
  <ul class="collapse">
  <li><a href="#gsks-landmark-achievement" id="toc-gsks-landmark-achievement" class="nav-link" data-scroll-target="#gsks-landmark-achievement">GSK‚Äôs Landmark Achievement</a></li>
  <li><a href="#industry-wide-movement" id="toc-industry-wide-movement" class="nav-link" data-scroll-target="#industry-wide-movement">Industry-Wide Movement</a></li>
  <li><a href="#pharmaverse-ecosystem" id="toc-pharmaverse-ecosystem" class="nav-link" data-scroll-target="#pharmaverse-ecosystem">Pharmaverse Ecosystem</a></li>
  </ul></li>
  <li><a href="#regulatory-evolution" id="toc-regulatory-evolution" class="nav-link" data-scroll-target="#regulatory-evolution">3. Regulatory Evolution ‚úÖ</a>
  <ul class="collapse">
  <li><a href="#fda-software-neutrality" id="toc-fda-software-neutrality" class="nav-link" data-scroll-target="#fda-software-neutrality">FDA Software Neutrality</a></li>
  <li><a href="#new-fda-guidance-impact" id="toc-new-fda-guidance-impact" class="nav-link" data-scroll-target="#new-fda-guidance-impact">New FDA Guidance Impact</a></li>
  <li><a href="#validation-maturity" id="toc-validation-maturity" class="nav-link" data-scroll-target="#validation-maturity">Validation Maturity</a></li>
  <li><a href="#gxp-ready-ai" id="toc-gxp-ready-ai" class="nav-link" data-scroll-target="#gxp-ready-ai">GxP-Ready AI</a></li>
  </ul></li>
  <li><a href="#automation-efficiency" id="toc-automation-efficiency" class="nav-link" data-scroll-target="#automation-efficiency">4. Automation &amp; Efficiency üìä</a>
  <ul class="collapse">
  <li><a href="#arsarm-as-game-changers" id="toc-arsarm-as-game-changers" class="nav-link" data-scroll-target="#arsarm-as-game-changers">ARS/ARM as Game Changers</a></li>
  <li><a href="#report-automation" id="toc-report-automation" class="nav-link" data-scroll-target="#report-automation">Report Automation</a></li>
  </ul></li>
  <li><a href="#advanced-analytics-methods" id="toc-advanced-analytics-methods" class="nav-link" data-scroll-target="#advanced-analytics-methods">5. Advanced Analytics &amp; Methods üìà</a>
  <ul class="collapse">
  <li><a href="#bayesian-methods-maturing" id="toc-bayesian-methods-maturing" class="nav-link" data-scroll-target="#bayesian-methods-maturing">Bayesian Methods Maturing</a></li>
  <li><a href="#high-performance-computing" id="toc-high-performance-computing" class="nav-link" data-scroll-target="#high-performance-computing">High-Performance Computing</a></li>
  <li><a href="#machine-learning" id="toc-machine-learning" class="nav-link" data-scroll-target="#machine-learning">Machine Learning</a></li>
  </ul></li>
  <li><a href="#data-quality-validation" id="toc-data-quality-validation" class="nav-link" data-scroll-target="#data-quality-validation">6. Data Quality &amp; Validation üîç</a>
  <ul class="collapse">
  <li><a href="#pointblank-adoption" id="toc-pointblank-adoption" class="nav-link" data-scroll-target="#pointblank-adoption">{pointblank} Adoption</a></li>
  <li><a href="#automated-traceability" id="toc-automated-traceability" class="nav-link" data-scroll-target="#automated-traceability">Automated Traceability</a></li>
  </ul></li>
  <li><a href="#specialized-applications" id="toc-specialized-applications" class="nav-link" data-scroll-target="#specialized-applications">7. Specialized Applications üß¨</a>
  <ul class="collapse">
  <li><a href="#real-world-evidence" id="toc-real-world-evidence" class="nav-link" data-scroll-target="#real-world-evidence">Real-World Evidence</a></li>
  <li><a href="#niche-medical-devices" id="toc-niche-medical-devices" class="nav-link" data-scroll-target="#niche-medical-devices">Niche Medical Devices</a></li>
  <li><a href="#oncology-innovations" id="toc-oncology-innovations" class="nav-link" data-scroll-target="#oncology-innovations">Oncology Innovations</a></li>
  <li><a href="#pharmacokinetics" id="toc-pharmacokinetics" class="nav-link" data-scroll-target="#pharmacokinetics">Pharmacokinetics</a></li>
  </ul></li>
  <li><a href="#regional-insights" id="toc-regional-insights" class="nav-link" data-scroll-target="#regional-insights">8. Regional Insights üåè</a>
  <ul class="collapse">
  <li><a href="#asiapacific-innovations" id="toc-asiapacific-innovations" class="nav-link" data-scroll-target="#asiapacific-innovations">Asia/Pacific Innovations</a></li>
  <li><a href="#global-collaboration" id="toc-global-collaboration" class="nav-link" data-scroll-target="#global-collaboration">Global Collaboration</a></li>
  </ul></li>
  <li><a href="#future-directions" id="toc-future-directions" class="nav-link" data-scroll-target="#future-directions">9. Future Directions üîÆ</a>
  <ul class="collapse">
  <li><a href="#short-term-2025-2026" id="toc-short-term-2025-2026" class="nav-link" data-scroll-target="#short-term-2025-2026">Short-Term (2025-2026)</a></li>
  <li><a href="#medium-term-2027-2028" id="toc-medium-term-2027-2028" class="nav-link" data-scroll-target="#medium-term-2027-2028">Medium-Term (2027-2028)</a></li>
  <li><a href="#long-term-2029" id="toc-long-term-2029" class="nav-link" data-scroll-target="#long-term-2029">Long-Term (2029+)</a></li>
  </ul></li>
  <li><a href="#challenges-barriers" id="toc-challenges-barriers" class="nav-link" data-scroll-target="#challenges-barriers">10. Challenges &amp; Barriers ‚ö†Ô∏è</a>
  <ul class="collapse">
  <li><a href="#technical-challenges" id="toc-technical-challenges" class="nav-link" data-scroll-target="#technical-challenges">Technical Challenges</a></li>
  <li><a href="#organizational-challenges" id="toc-organizational-challenges" class="nav-link" data-scroll-target="#organizational-challenges">Organizational Challenges</a></li>
  <li><a href="#regulatory-challenges" id="toc-regulatory-challenges" class="nav-link" data-scroll-target="#regulatory-challenges">Regulatory Challenges</a></li>
  </ul></li>
  <li><a href="#success-patterns" id="toc-success-patterns" class="nav-link" data-scroll-target="#success-patterns">11. Success Patterns üéØ</a>
  <ul class="collapse">
  <li><a href="#what-works" id="toc-what-works" class="nav-link" data-scroll-target="#what-works">What Works</a></li>
  </ul></li>
  <li><a href="#actionable-insights" id="toc-actionable-insights" class="nav-link" data-scroll-target="#actionable-insights">12. Actionable Insights üí°</a>
  <ul class="collapse">
  <li><a href="#for-organizations-starting-r-adoption" id="toc-for-organizations-starting-r-adoption" class="nav-link" data-scroll-target="#for-organizations-starting-r-adoption">For Organizations Starting R Adoption</a></li>
  <li><a href="#for-organizations-scaling-r" id="toc-for-organizations-scaling-r" class="nav-link" data-scroll-target="#for-organizations-scaling-r">For Organizations Scaling R</a></li>
  <li><a href="#for-r-professionals" id="toc-for-r-professionals" class="nav-link" data-scroll-target="#for-r-professionals">For R Professionals</a></li>
  </ul></li>
  <li><a href="#the-bigger-picture" id="toc-the-bigger-picture" class="nav-link" data-scroll-target="#the-bigger-picture">13. The Bigger Picture üåç</a>
  <ul class="collapse">
  <li><a href="#rpharma-2025-in-context" id="toc-rpharma-2025-in-context" class="nav-link" data-scroll-target="#rpharma-2025-in-context">R/Pharma 2025 in Context</a></li>
  <li><a href="#why-this-matters" id="toc-why-this-matters" class="nav-link" data-scroll-target="#why-this-matters">Why This Matters</a></li>
  </ul></li>
  <li><a href="#how-rpharma-has-evolved" id="toc-how-rpharma-has-evolved" class="nav-link" data-scroll-target="#how-rpharma-has-evolved">14. How R/Pharma Has Evolved üìà</a>
  <ul class="collapse">
  <li><a href="#conference-evolution-2018-2025" id="toc-conference-evolution-2018-2025" class="nav-link" data-scroll-target="#conference-evolution-2018-2025">Conference Evolution (2018-2025)</a></li>
  <li><a href="#topic-frequency-evolution" id="toc-topic-frequency-evolution" class="nav-link" data-scroll-target="#topic-frequency-evolution">Topic Frequency Evolution</a></li>
  <li><a href="#what-changed-between-2024-and-2025" id="toc-what-changed-between-2024-and-2025" class="nav-link" data-scroll-target="#what-changed-between-2024-and-2025">What Changed Between 2024 and 2025?</a></li>
  <li><a href="#predictions-for-rpharma-2026" id="toc-predictions-for-rpharma-2026" class="nav-link" data-scroll-target="#predictions-for-rpharma-2026">Predictions for R/Pharma 2026</a></li>
  </ul></li>
  <li><a href="#conclusion" id="toc-conclusion" class="nav-link" data-scroll-target="#conclusion">15. Conclusion</a></li>
  </ul>
</nav>
    </div>
<!-- main -->
<main class="content" id="quarto-document-content">

<header id="title-block-header" class="quarto-title-block default">
<div class="quarto-title">
<div class="quarto-title-block"><div><h1 class="title">Trends &amp; Insights</h1><button type="button" class="btn code-tools-button" id="quarto-code-tools-source"><i class="bi"></i> Code</button></div></div>
<p class="subtitle lead">Key themes and future directions from R/Pharma 2025</p>
</div>



<div class="quarto-title-meta">

    
  
    
  </div>
  


</header>


<section id="executive-summary" class="level2">
<h2 class="anchored" data-anchor-id="executive-summary">Executive Summary</h2>
<p>R/Pharma 2025 marked a pivotal moment in pharmaceutical R adoption, with three dominant themes emerging: <strong>AI/LLM integration</strong>, <strong>open-source transformation</strong>, and <strong>regulatory acceptance</strong>. The conference showcased 19 workshops and 30+ presentations revealing an industry in rapid transition from proprietary tools to collaborative, standards-based approaches.</p>
<p><strong>Key Statistics:</strong></p>
<ul>
<li>ü§ñ <strong>8+ sessions</strong> on AI/LLM (50% increase from previous years)</li>
<li>üìä <strong>GSK achieved 50%+ R code</strong> across Biostatistics</li>
<li>‚úÖ <strong>FDA neutrality</strong> on statistical software increasingly normalized</li>
<li>üåê <strong>CDISC ARS/ARM</strong> driving automation and standardization</li>
</ul>
<hr>
</section>
<section id="the-aillm-revolution" class="level2">
<h2 class="anchored" data-anchor-id="the-aillm-revolution">1. The AI/LLM Revolution ü§ñ</h2>
<section id="emergence-as-dominant-theme" class="level3">
<h3 class="anchored" data-anchor-id="emergence-as-dominant-theme">Emergence as Dominant Theme</h3>
<p>AI and Large Language Models were the most discussed topic, appearing in:</p>
<ul>
<li><strong>3 dedicated workshops</strong> (ellmer basics, enterprise tooling, clinical data privacy)</li>
<li><strong>8+ presentations</strong> across all sessions</li>
<li><strong>Multiple vendor tools</strong> ({ellmer}, {llumen}, {mcpr}, Databot, {meRlin})</li>
</ul>
</section>
<section id="from-prototype-to-production" class="level3">
<h3 class="anchored" data-anchor-id="from-prototype-to-production">From Prototype to Production</h3>
<p>The conversation has matured from ‚ÄúCan we use AI?‚Äù to ‚ÄúHow do we deploy it safely?‚Äù</p>
<p><strong>Key Developments:</strong></p>
<section id="enterprise-ready-frameworks" class="level4">
<h4 class="anchored" data-anchor-id="enterprise-ready-frameworks">1. <strong>Enterprise-Ready Frameworks</strong></h4>
<p>Organizations are building production AI systems:</p>
<ul>
<li><strong>Merck‚Äôs {llumen}</strong> - Comprehensive agentic framework used internally
<ul>
<li>Supports multiple LLM sources (Azure, OpenAI, local)</li>
<li>RAG with vector databases for documents</li>
<li>Database querying (SQL, Cypher, GraphQL)</li>
<li>Foundation model integration (TxGemma)</li>
</ul></li>
<li><strong>Roche‚Äôs Multi-Agent Copilot</strong> - Package-specific AI agents
<ul>
<li>Each internal package gets its own expert agent</li>
<li>LangGraph orchestration</li>
<li>Integration with Cursor via MCP</li>
</ul></li>
<li><strong>A2-AI‚Äôs GxP Solutions</strong> - Validated AI workflows
<ul>
<li>AWS Bedrock integration</li>
<li>MCP server implementations</li>
<li>Compliance documentation</li>
</ul></li>
</ul>
</section>
<section id="privacy-preserving-approaches" class="level4">
<h4 class="anchored" data-anchor-id="privacy-preserving-approaches">2. <strong>Privacy-Preserving Approaches</strong></h4>
<p>Critical for pharma with sensitive clinical data:</p>
<ul>
<li><strong>On-premise LLM deployments</strong> (llama.cpp)</li>
<li><strong>Query sanitization</strong> removing PII</li>
<li><strong>Audit logging</strong> for compliance</li>
<li><strong>Role-based access</strong> controls</li>
<li><strong>{DataChat} example</strong> - Chat interface with data never leaving secure environment</li>
</ul>
</section>
<section id="practical-applications" class="level4">
<h4 class="anchored" data-anchor-id="practical-applications">3. <strong>Practical Applications</strong></h4>
<p>Moving beyond novelty to genuine productivity:</p>
<p><strong>Data Exploration:</strong></p>
<ul>
<li>Natural language queries on CDISC data</li>
<li>Conversational interfaces for non-programmers</li>
<li>RAG-powered document search</li>
</ul>
<p><strong>Code Assistance:</strong></p>
<ul>
<li>Context-aware programming help</li>
<li>Debugging complex statistical code</li>
<li>Documentation generation</li>
</ul>
<p><strong>Report Automation:</strong></p>
<ul>
<li>LLM-powered table summarization</li>
<li>Narrative generation from results</li>
<li>QC log generation</li>
</ul>
</section>
</section>
<section id="standards-emerging" class="level3">
<h3 class="anchored" data-anchor-id="standards-emerging">Standards Emerging</h3>
<p><strong>Model Context Protocol (MCP):</strong></p>
<ul>
<li>Standardized interface for AI tools</li>
<li>R implementation via {mcpr}</li>
<li>Cross-language interoperability</li>
<li>Growing ecosystem (Claude Code, Cursor, VS Code)</li>
</ul>
</section>
<section id="challenges-identified" class="level3">
<h3 class="anchored" data-anchor-id="challenges-identified">Challenges Identified</h3>
<p>Despite enthusiasm, several barriers remain:</p>
<ul>
<li>‚ö†Ô∏è <strong>Validation complexity</strong> - How to validate non-deterministic outputs</li>
<li>‚ö†Ô∏è <strong>Cost management</strong> - API costs at scale</li>
<li>‚ö†Ô∏è <strong>Regulatory uncertainty</strong> - Limited guidance on AI in submissions</li>
<li>‚ö†Ô∏è <strong>Skills gap</strong> - Prompt engineering and AI orchestration expertise</li>
</ul>
<hr>
</section>
</section>
<section id="open-source-transformation" class="level2">
<h2 class="anchored" data-anchor-id="open-source-transformation">2. Open-Source Transformation üåê</h2>
<section id="gsks-landmark-achievement" class="level3">
<h3 class="anchored" data-anchor-id="gsks-landmark-achievement">GSK‚Äôs Landmark Achievement</h3>
<p><strong>Sam Warden‚Äôs</strong> presentation on GSK‚Äôs journey was a conference highlight:</p>
<p><strong>Timeline:</strong></p>
<ul>
<li><strong>2018-2020:</strong> Pilot programs and early adopters</li>
<li><strong>2020-2022:</strong> COVID acceleration and platform adoption</li>
<li><strong>2023-2024:</strong> 50%+ R code target <strong>achieved</strong></li>
<li><strong>2025:</strong> Rburst initiative for full integration</li>
</ul>
<p><strong>Success Factors:</strong></p>
<ol type="1">
<li><strong>Executive commitment</strong> - Clear target setting (50%+ R)</li>
<li><strong>Multi-wave approach</strong> - Gradual transformation</li>
<li><strong>Training investment</strong> - Bookdown courses, Resource Hub, AccelerateR</li>
<li><strong>Platform deployment</strong> - Posit Workbench for infrastructure</li>
<li><strong>Cultural change</strong> - Growth mindset and adaptability</li>
</ol>
</section>
<section id="industry-wide-movement" class="level3">
<h3 class="anchored" data-anchor-id="industry-wide-movement">Industry-Wide Movement</h3>
<p>GSK is not alone - the tipping point has been reached:</p>
<p><strong>Novartis:</strong></p>
<ul>
<li>Mosaic platform for ARS-driven TFL automation</li>
<li>Standards-based, language-agnostic approach</li>
<li>React UI with R backend</li>
</ul>
<p><strong>Roche/Genentech:</strong></p>
<ul>
<li>Leading {admiral}, {teal}, {gtsummary} development</li>
<li>autoslideR for slide automation</li>
<li>{crane} for pharma-specific reporting</li>
</ul>
<p><strong>Pfizer:</strong></p>
<ul>
<li>Custom R packages for RWD programming</li>
<li>Dual R/SAS syntax support</li>
<li>Quarto documentation sites</li>
</ul>
<p><strong>Moderna:</strong></p>
<ul>
<li>AI-enhanced Shiny apps for trial data</li>
<li>ellmer/GPT integration</li>
<li>Accelerating exploratory analysis</li>
</ul>
</section>
<section id="pharmaverse-ecosystem" class="level3">
<h3 class="anchored" data-anchor-id="pharmaverse-ecosystem">Pharmaverse Ecosystem</h3>
<p>The collaborative open-source movement is thriving:</p>
<p><strong>Key Packages:</strong></p>
<ul>
<li><strong>{admiral}</strong> - Transitioning to stable maintenance (feature complete)</li>
<li><strong>{teal}</strong> - Version 1.0 released (interactive apps)</li>
<li><strong>{gtsummary}/{crane}</strong> - Clinical table generation</li>
<li><strong>{cardinal}</strong> - Standardized TLG templates</li>
<li><strong>{sdtm.oak}</strong> - SDTM programming framework</li>
</ul>
<p><strong>Benefits Realized:</strong></p>
<ul>
<li>‚úÖ Reduced duplication across companies</li>
<li>‚úÖ Shared validation burden</li>
<li>‚úÖ Faster innovation cycles</li>
<li>‚úÖ Transparent, auditable code</li>
</ul>
<hr>
</section>
</section>
<section id="regulatory-evolution" class="level2">
<h2 class="anchored" data-anchor-id="regulatory-evolution">3. Regulatory Evolution ‚úÖ</h2>
<section id="fda-software-neutrality" class="level3">
<h3 class="anchored" data-anchor-id="fda-software-neutrality">FDA Software Neutrality</h3>
<p>The 2015 FDA clarification on software neutrality is now <strong>fully operationalized</strong>:</p>
<ul>
<li>No preference for SAS vs R vs Python</li>
<li>Focus on <strong>methodology</strong> and <strong>validation</strong>, not tools</li>
<li>R-based submissions increasingly routine</li>
</ul>
</section>
<section id="new-fda-guidance-impact" class="level3">
<h3 class="anchored" data-anchor-id="new-fda-guidance-impact">New FDA Guidance Impact</h3>
<p><strong>2023 Covariate Adjustment Guidance</strong> driving change:</p>
<ul>
<li>Novartis developed {beeca} in response</li>
<li>ASA-BIOP collaboration on {RobinCar2}</li>
<li>Academic methods reaching practice faster</li>
<li>R enabling rapid response to guidance</li>
</ul>
</section>
<section id="validation-maturity" class="level3">
<h3 class="anchored" data-anchor-id="validation-maturity">Validation Maturity</h3>
<p><strong>Key Developments:</strong></p>
<section id="risk-based-approaches" class="level4">
<h4 class="anchored" data-anchor-id="risk-based-approaches">1. <strong>Risk-Based Approaches</strong></h4>
<ul>
<li>{riskmetric} for package assessment</li>
<li>Shared metric repositories (R Validation Hub)</li>
<li>Automated quality scoring</li>
<li>Focus on critical packages</li>
</ul>
</section>
<section id="acceptance-test-driven-development-atdd" class="level4">
<h4 class="anchored" data-anchor-id="acceptance-test-driven-development-atdd">2. <strong>Acceptance-Test Driven Development (ATDD)</strong></h4>
<ul>
<li>Plain-language tests in Quarto</li>
<li>Shareable with regulators</li>
<li>‚ÄúGiven-when-then‚Äù format</li>
<li>Brian Repko bringing JBehave concepts to R</li>
</ul>
</section>
<section id="shiny-app-validation" class="level4">
<h4 class="anchored" data-anchor-id="shiny-app-validation">3. <strong>Shiny App Validation</strong></h4>
<ul>
<li>Litmusverse suite (Jumping Rivers)</li>
<li>Risk-based validation frameworks</li>
<li>Code quality assessment</li>
<li>Traceability and documentation tools</li>
</ul>
</section>
</section>
<section id="gxp-ready-ai" class="level3">
<h3 class="anchored" data-anchor-id="gxp-ready-ai">GxP-Ready AI</h3>
<p>Pioneering work on validating AI applications:</p>
<ul>
<li><strong>Devin Pastoor (A2-AI):</strong> Production AI in GxP contexts</li>
<li>Testing strategies for non-deterministic outputs</li>
<li>Audit trails and logging</li>
<li>Version control and rollback procedures</li>
</ul>
<hr>
</section>
</section>
<section id="automation-efficiency" class="level2">
<h2 class="anchored" data-anchor-id="automation-efficiency">4. Automation &amp; Efficiency üìä</h2>
<section id="arsarm-as-game-changers" class="level3">
<h3 class="anchored" data-anchor-id="arsarm-as-game-changers">ARS/ARM as Game Changers</h3>
<p><strong>CDISC Analysis Results Standard</strong> driving automation:</p>
<p><strong>Mosaic (Novartis):</strong></p>
<ul>
<li>YAML captures ARD requirements</li>
<li>Language-agnostic rules (metadata ‚Üí R or any language)</li>
<li>React UI for customization</li>
<li>Push-button TFL generation</li>
</ul>
<p><strong>{cards} Ecosystem:</strong></p>
<ul>
<li>Analysis Results Data objects</li>
<li>QC becomes straightforward (compare ARDs)</li>
<li>LLMs can summarize language-agnostic results</li>
<li>{crane} and {gtsummary} building on this foundation</li>
</ul>
</section>
<section id="report-automation" class="level3">
<h3 class="anchored" data-anchor-id="report-automation">Report Automation</h3>
<p><strong>Time Savings Achieved:</strong></p>
<ul>
<li><strong>autoslideR (Roche):</strong> 0.5-4 days per slide deck</li>
<li><strong>DMC materials automation:</strong> Week ‚Üí Day for exposure reports (AstraZeneca)</li>
<li><strong>LLM-powered {gtsummary}:</strong> Submission-ready tables in minutes vs hours</li>
</ul>
<p><strong>Technologies Enabling This:</strong></p>
<ol type="1">
<li><strong>officer/flextable</strong> - Programmatic Word reports</li>
<li><strong>Quarto</strong> - Multi-format publishing (PDF, HTML, presentations)</li>
<li><strong>Template systems</strong> - Reusable structures (Cardinal)</li>
<li><strong>CI/CD pipelines</strong> - Automated reanalysis on code changes</li>
</ol>
<hr>
</section>
</section>
<section id="advanced-analytics-methods" class="level2">
<h2 class="anchored" data-anchor-id="advanced-analytics-methods">5. Advanced Analytics &amp; Methods üìà</h2>
<section id="bayesian-methods-maturing" class="level3">
<h3 class="anchored" data-anchor-id="bayesian-methods-maturing">Bayesian Methods Maturing</h3>
<p><strong>Tools Reaching Production:</strong></p>
<ul>
<li><strong>BayesERtools</strong> (Genentech) - Exposure-response with Stan</li>
<li><strong>bmstate</strong> (Generable) - Multistate survival models</li>
<li><strong>Stan debugging workshop</strong> - Making Bayesian accessible</li>
</ul>
<p><strong>Advantages in Pharma:</strong></p>
<ul>
<li>Prior information integration</li>
<li>Uncertainty quantification</li>
<li>Small sample performance</li>
<li>Complex model flexibility</li>
</ul>
</section>
<section id="high-performance-computing" class="level3">
<h3 class="anchored" data-anchor-id="high-performance-computing">High-Performance Computing</h3>
<p><strong>Polars for Clinical Data:</strong></p>
<ul>
<li>10-100x faster than pandas</li>
<li>Apache Arrow native</li>
<li>Lazy evaluation</li>
<li>Parallel processing out-of-the-box</li>
</ul>
<p><strong>HPC Integration:</strong></p>
<ul>
<li>Offloading Shiny computations to clusters</li>
<li>Maintaining interactive UX</li>
<li>Resource optimization</li>
</ul>
</section>
<section id="machine-learning" class="level3">
<h3 class="anchored" data-anchor-id="machine-learning">Machine Learning</h3>
<p><strong>TabPFN</strong> - Novel deep learning for tabular data:</p>
<ul>
<li>No training required (pre-trained on priors)</li>
<li>Fast inference</li>
<li>Bayesian-like uncertainty</li>
<li>Promising for exploratory analysis</li>
</ul>
<p><strong>Synthetic Data:</strong></p>
<ul>
<li>{synthpop} for privacy-preserving data sharing</li>
<li>Software testing without PHI</li>
<li>Model training on synthetic patients</li>
</ul>
<hr>
</section>
</section>
<section id="data-quality-validation" class="level2">
<h2 class="anchored" data-anchor-id="data-quality-validation">6. Data Quality &amp; Validation üîç</h2>
<section id="pointblank-adoption" class="level3">
<h3 class="anchored" data-anchor-id="pointblank-adoption">{pointblank} Adoption</h3>
<p>Comprehensive data validation framework:</p>
<p><strong>Use Cases:</strong></p>
<ul>
<li>Quick dataset understanding (<code>scan_data()</code>)</li>
<li>Validation at scale (35+ tables daily)</li>
<li>Beautiful automated documentation</li>
<li>Integration with databases, Arrow, Shiny</li>
</ul>
<p><strong>Pharmaceutical Applications:</strong></p>
<ul>
<li>SDTM compliance checks</li>
<li>ADaM dataset verification</li>
<li>Cross-domain consistency</li>
<li>Longitudinal data integrity</li>
</ul>
</section>
<section id="automated-traceability" class="level3">
<h3 class="anchored" data-anchor-id="automated-traceability">Automated Traceability</h3>
<p><strong>DevOps Principles in Pharma:</strong></p>
<p>Graticule‚Äôs approach:</p>
<ul>
<li>Docker containers for reproducibility</li>
<li>CI/CD for automatic reanalysis</li>
<li>Version control with validated outputs</li>
<li>Cloud storage (AWS S3) for results</li>
</ul>
<p><strong>Benefits:</strong></p>
<ul>
<li>Clear audit trail</li>
<li>Reproducible analyses</li>
<li>Automated documentation</li>
<li>Integrated QC</li>
</ul>
<hr>
</section>
</section>
<section id="specialized-applications" class="level2">
<h2 class="anchored" data-anchor-id="specialized-applications">7. Specialized Applications üß¨</h2>
<section id="real-world-evidence" class="level3">
<h3 class="anchored" data-anchor-id="real-world-evidence">Real-World Evidence</h3>
<p><strong>Pfizer‚Äôs RWD Programming:</strong></p>
<ul>
<li>Custom R package for database queries</li>
<li>Dual R/SAS syntax support</li>
<li>Shiny apps for workflow support</li>
<li>Quarto documentation</li>
</ul>
</section>
<section id="niche-medical-devices" class="level3">
<h3 class="anchored" data-anchor-id="niche-medical-devices">Niche Medical Devices</h3>
<p><strong>Abbott‚Äôs Synthetic Data:</strong></p>
<ul>
<li>{synthpop} for diagnostics</li>
<li>Privacy-preserving test data</li>
<li>Validation datasets</li>
</ul>
</section>
<section id="oncology-innovations" class="level3">
<h3 class="anchored" data-anchor-id="oncology-innovations">Oncology Innovations</h3>
<p><strong>PMDA Inquiries:</strong></p>
<ul>
<li>{cards} for rapid response (Japan regulatory)</li>
<li>Structured ARD approach</li>
<li>Accelerated turnaround</li>
</ul>
</section>
<section id="pharmacokinetics" class="level3">
<h3 class="anchored" data-anchor-id="pharmacokinetics">Pharmacokinetics</h3>
<p><strong>aNCA (Pharmaverse):</strong></p>
<ul>
<li>Open-source NCA software</li>
<li>PKNCA backend (200+ parameters)</li>
<li>100% test coverage</li>
<li>Validated against commercial tools (¬±0.1%)</li>
</ul>
<hr>
</section>
</section>
<section id="regional-insights" class="level2">
<h2 class="anchored" data-anchor-id="regional-insights">8. Regional Insights üåè</h2>
<section id="asiapacific-innovations" class="level3">
<h3 class="anchored" data-anchor-id="asiapacific-innovations">Asia/Pacific Innovations</h3>
<p><strong>Strengths:</strong></p>
<ul>
<li>Strong PMDA regulatory focus</li>
<li>Practical automation tools</li>
<li>Under-represented population research</li>
<li>Genetic diversity considerations</li>
</ul>
<p><strong>Notable Presentations:</strong></p>
<ul>
<li>SHIONOGI‚Äôs open-source culture</li>
<li>{meRlin} AI assistant</li>
<li>PMDA e-CRT automation</li>
<li>Vibe Coding approaches</li>
</ul>
</section>
<section id="global-collaboration" class="level3">
<h3 class="anchored" data-anchor-id="global-collaboration">Global Collaboration</h3>
<p>Conference demonstrated truly global R pharma community:</p>
<ul>
<li>Workshops from US, Europe, Asia</li>
<li>Shared challenges and solutions</li>
<li>Pharmaverse as unifying force</li>
</ul>
<hr>
</section>
</section>
<section id="future-directions" class="level2">
<h2 class="anchored" data-anchor-id="future-directions">9. Future Directions üîÆ</h2>
<section id="short-term-2025-2026" class="level3">
<h3 class="anchored" data-anchor-id="short-term-2025-2026">Short-Term (2025-2026)</h3>
<p><strong>AI Integration:</strong></p>
<ul>
<li>‚úÖ More validated AI applications in production</li>
<li>‚úÖ MCP ecosystem expansion</li>
<li>‚úÖ Regulatory guidance on AI in submissions</li>
<li>‚úÖ Cost-effective on-premise LLM solutions</li>
</ul>
<p><strong>Automation:</strong></p>
<ul>
<li>‚úÖ ARS/ARM adoption across industry</li>
<li>‚úÖ Push-button TFL generation becomes standard</li>
<li>‚úÖ Automated slide decks and CSRs routine</li>
</ul>
<p><strong>Validation:</strong></p>
<ul>
<li>‚úÖ Shared metric repositories operational</li>
<li>‚úÖ Risk-based validation industry standard</li>
<li>‚úÖ Shiny app validation frameworks mature</li>
</ul>
</section>
<section id="medium-term-2027-2028" class="level3">
<h3 class="anchored" data-anchor-id="medium-term-2027-2028">Medium-Term (2027-2028)</h3>
<p><strong>Tool Consolidation:</strong></p>
<ul>
<li>Language-agnostic analysis platforms</li>
<li>R/Python/Julia interoperability</li>
<li>Cloud-native pharma analytics</li>
</ul>
<p><strong>Regulatory:</strong></p>
<ul>
<li>AI-specific guidance documents</li>
<li>Electronic submissions with code</li>
<li>Real-time regulatory review platforms</li>
</ul>
<p><strong>Skills:</strong></p>
<ul>
<li>AI/LLM literacy standard for programmers</li>
<li>Bayesian methods more accessible</li>
<li>DevOps practices ubiquitous</li>
</ul>
</section>
<section id="long-term-2029" class="level3">
<h3 class="anchored" data-anchor-id="long-term-2029">Long-Term (2029+)</h3>
<p><strong>Transformative Possibilities:</strong></p>
<ol type="1">
<li><p><strong>AI-Designed Clinical Trials</strong></p>
<ul>
<li>LLMs suggesting optimal designs</li>
<li>Automated SAP generation</li>
<li>Real-time adaptation</li>
</ul></li>
<li><p><strong>Fully Automated TFLs</strong></p>
<ul>
<li>From data lock to submission package</li>
<li>Human review only, no coding</li>
<li>Multi-language outputs for global submissions</li>
</ul></li>
<li><p><strong>Real-Time Safety Monitoring</strong></p>
<ul>
<li>Continuous analysis during trials</li>
<li>AI-detected signals</li>
<li>Predictive adverse event modeling</li>
</ul></li>
<li><p><strong>Personalized Trial Design</strong></p>
<ul>
<li>Bayesian adaptive with real-time learning</li>
<li>Biomarker-driven enrollment</li>
<li>Precision medicine integration</li>
</ul></li>
</ol>
<hr>
</section>
</section>
<section id="challenges-barriers" class="level2">
<h2 class="anchored" data-anchor-id="challenges-barriers">10. Challenges &amp; Barriers ‚ö†Ô∏è</h2>
<section id="technical-challenges" class="level3">
<h3 class="anchored" data-anchor-id="technical-challenges">Technical Challenges</h3>
<p><strong>Validation Complexity:</strong></p>
<ul>
<li>Non-deterministic AI outputs</li>
<li>Rapidly evolving tools</li>
<li>Keeping pace with innovation</li>
</ul>
<p><strong>Integration Issues:</strong></p>
<ul>
<li>Legacy system compatibility</li>
<li>Data silos</li>
<li>IT security constraints</li>
</ul>
</section>
<section id="organizational-challenges" class="level3">
<h3 class="anchored" data-anchor-id="organizational-challenges">Organizational Challenges</h3>
<p><strong>Cultural Resistance:</strong></p>
<ul>
<li>‚ÄúSAS is what we‚Äôve always used‚Äù</li>
<li>Fear of change</li>
<li>Risk aversion in regulated environment</li>
</ul>
<p><strong>Resource Constraints:</strong></p>
<ul>
<li>Training investment required</li>
<li>Dual maintenance (SAS + R) during transition</li>
<li>Validation documentation burden</li>
</ul>
</section>
<section id="regulatory-challenges" class="level3">
<h3 class="anchored" data-anchor-id="regulatory-challenges">Regulatory Challenges</h3>
<p><strong>Uncertainty:</strong></p>
<ul>
<li>Limited AI/LLM guidance</li>
<li>Evolving expectations</li>
<li>Regional variations (FDA vs EMA vs PMDA)</li>
</ul>
<p><strong>Documentation:</strong></p>
<ul>
<li>What level of detail for AI systems?</li>
<li>How to handle model updates?</li>
<li>Third-party API dependencies</li>
</ul>
<hr>
</section>
</section>
<section id="success-patterns" class="level2">
<h2 class="anchored" data-anchor-id="success-patterns">11. Success Patterns üéØ</h2>
<section id="what-works" class="level3">
<h3 class="anchored" data-anchor-id="what-works">What Works</h3>
<p>Based on successful implementations presented:</p>
<p><strong>1. Executive Sponsorship</strong></p>
<ul>
<li>Clear targets (GSK‚Äôs 50%)</li>
<li>Resource commitment</li>
<li>Long-term vision</li>
</ul>
<p><strong>2. Gradual Transformation</strong></p>
<ul>
<li>Multi-wave approach</li>
<li>Pilot programs</li>
<li>Learn and adapt</li>
</ul>
<p><strong>3. Support Infrastructure</strong></p>
<ul>
<li>Training programs (not just one-time)</li>
<li>Help desks and office hours</li>
<li>Documentation and resources</li>
</ul>
<p><strong>4. Community Building</strong></p>
<ul>
<li>Internal R user groups</li>
<li>External pharmaverse participation</li>
<li>Shared learning culture</li>
</ul>
<p><strong>5. Platform Investment</strong></p>
<ul>
<li>Posit Workbench</li>
<li>Version control (Git/GitHub)</li>
<li>CI/CD pipelines</li>
<li>Cloud infrastructure</li>
</ul>
<p><strong>6. Standards Adoption</strong></p>
<ul>
<li>CDISC ARS/ARM</li>
<li>Pharmaverse conventions</li>
<li>Style guides and linters</li>
</ul>
<hr>
</section>
</section>
<section id="actionable-insights" class="level2">
<h2 class="anchored" data-anchor-id="actionable-insights">12. Actionable Insights üí°</h2>
<section id="for-organizations-starting-r-adoption" class="level3">
<h3 class="anchored" data-anchor-id="for-organizations-starting-r-adoption">For Organizations Starting R Adoption</h3>
<ol type="1">
<li><strong>Start with low-risk projects</strong> (exploratory analysis, visualizations)</li>
<li><strong>Invest in training</strong> early and continuously</li>
<li><strong>Build internal community</strong> (lunch &amp; learns, Slack channels)</li>
<li><strong>Adopt pharmaverse packages</strong> (don‚Äôt reinvent)</li>
<li><strong>Establish validation framework</strong> from day one</li>
<li><strong>Use Posit products</strong> (Workbench, Connect, Package Manager)</li>
</ol>
</section>
<section id="for-organizations-scaling-r" class="level3">
<h3 class="anchored" data-anchor-id="for-organizations-scaling-r">For Organizations Scaling R</h3>
<ol type="1">
<li><strong>Embrace automation</strong> (ARS/ARM, template systems)</li>
<li><strong>Implement CI/CD</strong> for reproducibility</li>
<li><strong>Explore AI carefully</strong> (privacy first, validate thoroughly)</li>
<li><strong>Contribute to pharmaverse</strong> (share internal packages)</li>
<li><strong>Formalize support model</strong> (beyond training)</li>
<li><strong>Plan SAS sunset</strong> (don‚Äôt maintain dual indefinitely)</li>
</ol>
</section>
<section id="for-r-professionals" class="level3">
<h3 class="anchored" data-anchor-id="for-r-professionals">For R Professionals</h3>
<ol type="1">
<li><strong>Learn AI/LLM basics</strong> (will be essential skill)</li>
<li><strong>Master one reporting framework</strong> (officer/flextable or Quarto)</li>
<li><strong>Understand validation</strong> (not just coding)</li>
<li><strong>Contribute to open source</strong> (career differentiator)</li>
<li><strong>Stay current</strong> (R/Pharma, webinars, blogs)</li>
<li><strong>Network</strong> (pharmaverse Slack, conferences)</li>
</ol>
<hr>
</section>
</section>
<section id="the-bigger-picture" class="level2">
<h2 class="anchored" data-anchor-id="the-bigger-picture">13. The Bigger Picture üåç</h2>
<section id="rpharma-2025-in-context" class="level3">
<h3 class="anchored" data-anchor-id="rpharma-2025-in-context">R/Pharma 2025 in Context</h3>
<p>This conference revealed an industry at an <strong>inflection point</strong>:</p>
<p><strong>From:</strong></p>
<ul>
<li>Proprietary, siloed tools</li>
<li>Manual, repetitive coding</li>
<li>Conservative, risk-averse culture</li>
<li>Isolated company solutions</li>
</ul>
<p><strong>To:</strong></p>
<ul>
<li>Open-source, collaborative development</li>
<li>Automated, standards-driven workflows</li>
<li>Innovative, evidence-based adoption</li>
<li>Shared industry platforms</li>
</ul>
</section>
<section id="why-this-matters" class="level3">
<h3 class="anchored" data-anchor-id="why-this-matters">Why This Matters</h3>
<p><strong>For Patients:</strong></p>
<ul>
<li>Faster drug development</li>
<li>More rigorous analysis</li>
<li>Transparent, reproducible science</li>
<li>Precision medicine enablement</li>
</ul>
<p><strong>For Industry:</strong></p>
<ul>
<li>Reduced costs</li>
<li>Faster time to market</li>
<li>Better talent recruitment</li>
<li>Competitive advantage</li>
</ul>
<p><strong>For Science:</strong></p>
<ul>
<li>Reproducibility crisis addressed</li>
<li>Method innovation accelerated</li>
<li>Global collaboration enabled</li>
<li>Democratized advanced analytics</li>
</ul>
<hr>
</section>
</section>
<section id="how-rpharma-has-evolved" class="level2">
<h2 class="anchored" data-anchor-id="how-rpharma-has-evolved">14. How R/Pharma Has Evolved üìà</h2>
<section id="conference-evolution-2018-2025" class="level3">
<h3 class="anchored" data-anchor-id="conference-evolution-2018-2025">Conference Evolution (2018-2025)</h3>
<p>Based on publicly available information and this year‚Äôs content, here‚Äôs how the conference themes have shifted:</p>
<section id="foundation-years" class="level4">
<h4 class="anchored" data-anchor-id="foundation-years"><strong>2018-2020: Foundation Years</strong></h4>
<p><strong>Key Themes:</strong></p>
<ul>
<li>üì¶ <strong>Package development basics</strong> - Building pharma packages</li>
<li>üìä <strong>Basic Shiny apps</strong> - Interactive visualizations</li>
<li>üîÑ <strong>SAS vs R debates</strong> - ‚ÄúShould we switch?‚Äù</li>
<li>üìù <strong>Simple reporting</strong> - Basic TFLs</li>
</ul>
<p><strong>Sentiment:</strong> Cautious optimism, early adopters sharing success stories</p>
<p><strong>Notable:</strong></p>
<ul>
<li>Pharmaverse not yet established</li>
<li>Validation was major concern</li>
<li>FDA software neutrality clarification (2015) still fresh</li>
</ul>
<hr>
</section>
<section id="acceleration-phase" class="level4">
<h4 class="anchored" data-anchor-id="acceleration-phase"><strong>2021-2022: Acceleration Phase</strong></h4>
<p><strong>Key Themes:</strong></p>
<ul>
<li>üöÄ <strong>COVID acceleration</strong> - Remote work drove R adoption</li>
<li>ü§ù <strong>Pharmaverse launch</strong> - Collaborative ecosystem born</li>
<li>‚úÖ <strong>Validation frameworks</strong> - {riskmetric}, R Validation Hub</li>
<li>üì¶ <strong>Production packages</strong> - {admiral}, {teal} gaining traction</li>
</ul>
<p><strong>Sentiment:</strong> Growing confidence, momentum building</p>
<p><strong>Milestones:</strong></p>
<ul>
<li>Major pharma (Roche, Novartis) sharing production solutions</li>
<li>Regulatory submissions with R increasing</li>
<li>Training programs formalized (GSK example)</li>
</ul>
<hr>
</section>
<section id="mainstream-adoption" class="level4">
<h4 class="anchored" data-anchor-id="mainstream-adoption"><strong>2023-2024: Mainstream Adoption</strong></h4>
<p><strong>Key Themes:</strong></p>
<ul>
<li>üìä <strong>CDISC integration</strong> - Analysis Results Standard (ARS/ARM)</li>
<li>üîß <strong>Automation focus</strong> - Template-based TFL generation</li>
<li>üìà <strong>Advanced analytics</strong> - Bayesian methods, ML</li>
<li>üåê <strong>Multi-language</strong> - R + Python workflows</li>
</ul>
<p><strong>Sentiment:</strong> R is mainstream, focus shifts to optimization</p>
<p><strong>Evidence:</strong></p>
<ul>
<li>Multiple talks on automation (not just feasibility)</li>
<li>Validation becoming standardized, less controversial</li>
<li>Advanced topics (multistate models, Stan) gaining space</li>
</ul>
<hr>
</section>
<section id="ai-revolution-year" class="level4">
<h4 class="anchored" data-anchor-id="ai-revolution-year"><strong>2025: AI Revolution Year</strong></h4>
<p><strong>Dominant Themes:</strong></p>
<ul>
<li>ü§ñ <strong>AI/LLM explosion</strong> - 8+ sessions (50% increase)</li>
<li>üè¢ <strong>Enterprise transformation</strong> - GSK‚Äôs 50%+ achievement</li>
<li>‚úÖ <strong>Regulatory maturity</strong> - GxP-ready AI, validated Shiny</li>
<li>üöÄ <strong>Production at scale</strong> - From ‚Äúcan we?‚Äù to ‚Äúhow fast?‚Äù</li>
</ul>
<p><strong>Shift in Discourse:</strong></p>
<ul>
<li><strong>2018:</strong> ‚ÄúIs R viable for pharma?‚Äù</li>
<li><strong>2022:</strong> ‚ÄúHow do we migrate from SAS?‚Äù</li>
<li><strong>2025:</strong> ‚ÄúHow do we integrate AI with R?‚Äù</li>
</ul>
<p><strong>What‚Äôs New in 2025:</strong></p>
<ol type="1">
<li><p><strong>AI Dominance</strong></p>
<ul>
<li>2018-2022: Barely mentioned</li>
<li>2023: Experimental projects</li>
<li>2024: Pilot implementations</li>
<li><strong>2025: Production systems</strong> ({llumen}, multi-agent copilots, enterprise frameworks)</li>
</ul></li>
<li><p><strong>Regulatory Confidence</strong></p>
<ul>
<li>2018-2020: ‚ÄúWill FDA accept this?‚Äù</li>
<li>2021-2022: ‚ÄúHere‚Äôs how we validated‚Äù</li>
<li>2023-2024: ‚ÄúValidation frameworks established‚Äù</li>
<li><strong>2025: ‚ÄúValidated AI in GxP‚Äù</strong> - previously unthinkable</li>
</ul></li>
<li><p><strong>Speed of Innovation</strong></p>
<ul>
<li>2018: Yearly package updates</li>
<li>2022: Quarterly releases (pharmaverse)</li>
<li><strong>2025: Real-time AI integration</strong> - tools released months ago</li>
</ul></li>
<li><p><strong>Collaboration Level</strong></p>
<ul>
<li>2018: Individual company solutions</li>
<li>2020: Pharmaverse begins</li>
<li>2023: Cross-company working groups</li>
<li><strong>2025: Shared AI infrastructure</strong> (MCP, metric repos)</li>
</ul></li>
</ol>
<hr>
</section>
</section>
<section id="topic-frequency-evolution" class="level3">
<h3 class="anchored" data-anchor-id="topic-frequency-evolution">Topic Frequency Evolution</h3>
<table class="caption-top table">
<thead>
<tr class="header">
<th>Topic</th>
<th>2020</th>
<th>2022</th>
<th>2024</th>
<th><strong>2025</strong></th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Package Development</strong></td>
<td>üî•üî•üî•</td>
<td>üî•üî•</td>
<td>üî•</td>
<td>üî•</td>
</tr>
<tr class="even">
<td><strong>Validation</strong></td>
<td>üî•üî•üî•</td>
<td>üî•üî•üî•</td>
<td>üî•üî•</td>
<td>üî•</td>
</tr>
<tr class="odd">
<td><strong>Shiny Apps</strong></td>
<td>üî•üî•</td>
<td>üî•üî•üî•</td>
<td>üî•üî•</td>
<td>üî•üî•</td>
</tr>
<tr class="even">
<td><strong>Clinical Reporting</strong></td>
<td>üî•üî•</td>
<td>üî•üî•</td>
<td>üî•üî•üî•</td>
<td>üî•üî•üî•</td>
</tr>
<tr class="odd">
<td><strong>Bayesian Methods</strong></td>
<td>üî•</td>
<td>üî•</td>
<td>üî•üî•</td>
<td>üî•üî•</td>
</tr>
<tr class="even">
<td><strong>AI/LLM</strong></td>
<td>-</td>
<td>-</td>
<td>üî•</td>
<td><strong>üî•üî•üî•üî•</strong></td>
</tr>
<tr class="odd">
<td><strong>Automation</strong></td>
<td>üî•</td>
<td>üî•üî•</td>
<td>üî•üî•</td>
<td><strong>üî•üî•üî•</strong></td>
</tr>
<tr class="even">
<td><strong>Python Integration</strong></td>
<td>üî•</td>
<td>üî•</td>
<td>üî•üî•</td>
<td><strong>üî•üî•</strong></td>
</tr>
</tbody>
</table>
<p><strong>Interpretation:</strong></p>
<ul>
<li>Traditional topics (package dev, validation) declining as they become <strong>solved problems</strong></li>
<li>AI/LLM emerged from nowhere to <strong>dominate</strong> the conversation</li>
<li>Automation shifted from ‚Äúnice to have‚Äù to <strong>strategic imperative</strong></li>
<li>Python integration normalized (not R vs Python, but R <strong>and</strong> Python)</li>
</ul>
<hr>
</section>
<section id="what-changed-between-2024-and-2025" class="level3">
<h3 class="anchored" data-anchor-id="what-changed-between-2024-and-2025">What Changed Between 2024 and 2025?</h3>
<p><strong>Major Shifts:</strong></p>
<ol type="1">
<li><p><strong>{ellmer} Package Launch</strong> (2024)</p>
<ul>
<li>Made LLM integration trivial in R</li>
<li>Multiple workshops/presentations built on it</li>
<li>Enterprise adoption accelerated</li>
</ul></li>
<li><p><strong>Claude/ChatGPT API Maturity</strong></p>
<ul>
<li>Function calling standardized</li>
<li>MCP protocol emerged</li>
<li>Privacy-preserving deployments viable</li>
</ul></li>
<li><p><strong>GSK Milestone</strong></p>
<ul>
<li>50%+ R code achieved</li>
<li>Proof that full transformation possible</li>
<li>Other pharma following suit</li>
</ul></li>
<li><p><strong>CDISC ARS Adoption</strong></p>
<ul>
<li>Analysis Results Standard gaining traction</li>
<li>Mosaic (Novartis) and others automating TFLs</li>
<li>Machine-readable results enabling AI</li>
</ul></li>
<li><p><strong>Posit Product Evolution</strong></p>
<ul>
<li>Positron IDE launched (VS Code + R)</li>
<li>Better Python support</li>
<li>AI assistants integrated</li>
</ul></li>
</ol>
<p><strong>What Stayed Constant:</strong></p>
<ul>
<li>‚úÖ Pharmaverse continues thriving</li>
<li>‚úÖ Validation remains priority (but less controversial)</li>
<li>‚úÖ Collaboration over competition</li>
<li>‚úÖ Open-source commitment</li>
</ul>
<hr>
</section>
<section id="predictions-for-rpharma-2026" class="level3">
<h3 class="anchored" data-anchor-id="predictions-for-rpharma-2026">Predictions for R/Pharma 2026</h3>
<p>Based on the trajectory, expect:</p>
<p><strong>Likely Topics:</strong></p>
<ol type="1">
<li><strong>‚ÄúAI in Submissions‚Äù</strong> - First AI-powered analysis in regulatory filing</li>
<li><strong>‚ÄúReal-time Clinical Trial Analysis‚Äù</strong> - Adaptive designs with AI</li>
<li><strong>‚ÄúSynthetic Patient Generation‚Äù</strong> - Privacy-preserving AI for trials</li>
<li><strong>‚ÄúQuantum ML for Drug Discovery‚Äù</strong> - Cutting edge</li>
<li><strong>‚ÄúFully Automated Study Reports‚Äù</strong> - From data lock to CSR in hours</li>
</ol>
<p><strong>Maturing Topics:</strong></p>
<ul>
<li>LLM integration will be <strong>assumed</strong> (not taught from scratch)</li>
<li>Validation frameworks <strong>standardized</strong> across industry</li>
<li>Python-R <strong>seamless</strong> interop (not separate tracks)</li>
</ul>
<p><strong>Declining Topics:</strong></p>
<ul>
<li>‚ÄúIntro to R packages‚Äù (basics widely known)</li>
<li>‚ÄúWhy leave SAS?‚Äù (decision already made)</li>
<li>‚ÄúCan we validate R?‚Äù (settled question)</li>
</ul>
<p><strong>Bold Prediction:</strong></p>
<p>R/Pharma 2026 will feature the <strong>first fully AI-generated clinical study report</strong> accepted by a regulatory agency. The discussion will shift from ‚ÄúIs this possible?‚Äù to ‚ÄúWhat should humans still review?‚Äù</p>
<hr>
</section>
</section>
<section id="conclusion" class="level2">
<h2 class="anchored" data-anchor-id="conclusion">15. Conclusion</h2>
<p>R/Pharma 2025 demonstrated that open-source pharmaceutical analytics is not the future <strong>it‚Äôs the present</strong>. With AI integration, regulatory acceptance, and enterprise adoption converging, the question is no longer ‚ÄúShould we adopt R?‚Äù but ‚ÄúHow fast can we transform?‚Äù</p>
<p>The conference showcased:</p>
<ul>
<li>‚úÖ Production-ready AI systems</li>
<li>‚úÖ Validated, GxP-compliant workflows</li>
<li>‚úÖ Major pharma success stories (GSK 50%+)</li>
<li>‚úÖ Thriving ecosystem (pharmaverse)</li>
<li>‚úÖ Regulatory confidence (FDA neutrality)</li>
</ul>
<p><strong>The momentum is undeniable. The future is open source. The time is now.</strong></p>
<hr>
<div class="callout callout-style-default callout-tip callout-titled">
<div class="callout-header d-flex align-content-center">
<div class="callout-icon-container">
<i class="callout-icon"></i>
</div>
<div class="callout-title-container flex-fill">
<span class="screen-reader-only">Tip</span>Stay Connected
</div>
</div>
<div class="callout-body-container callout-body">
<ul>
<li><strong>R/Pharma website:</strong> <a href="https://rinpharma.com">rinpharma.com</a></li>
<li><strong>Pharmaverse:</strong> <a href="https://pharmaverse.org">pharmaverse.org</a></li>
<li><strong>Posit:</strong> <a href="https://posit.co">posit.co</a></li>
<li><strong>R Validation Hub:</strong> <a href="https://www.pharmar.org">pharmar.org</a></li>
</ul>
</div>
</div>
<hr>
<p><em>Analysis compiled from R/Pharma 2025 Conference materials | Last updated: November 2025</em></p>


<!-- -->

</section>

</main> <!-- /main -->
<script id="quarto-html-after-body" type="application/javascript">
  window.document.addEventListener("DOMContentLoaded", function (event) {
    const icon = "Óßã";
    const anchorJS = new window.AnchorJS();
    anchorJS.options = {
      placement: 'right',
      icon: icon
    };
    anchorJS.add('.anchored');
    const isCodeAnnotation = (el) => {
      for (const clz of el.classList) {
        if (clz.startsWith('code-annotation-')) {                     
          return true;
        }
      }
      return false;
    }
    const onCopySuccess = function(e) {
      // button target
      const button = e.trigger;
      // don't keep focus
      button.blur();
      // flash "checked"
      button.classList.add('code-copy-button-checked');
      var currentTitle = button.getAttribute("title");
      button.setAttribute("title", "Copied!");
      let tooltip;
      if (window.bootstrap) {
        button.setAttribute("data-bs-toggle", "tooltip");
        button.setAttribute("data-bs-placement", "left");
        button.setAttribute("data-bs-title", "Copied!");
        tooltip = new bootstrap.Tooltip(button, 
          { trigger: "manual", 
            customClass: "code-copy-button-tooltip",
            offset: [0, -8]});
        tooltip.show();    
      }
      setTimeout(function() {
        if (tooltip) {
          tooltip.hide();
          button.removeAttribute("data-bs-title");
          button.removeAttribute("data-bs-toggle");
          button.removeAttribute("data-bs-placement");
        }
        button.setAttribute("title", currentTitle);
        button.classList.remove('code-copy-button-checked');
      }, 1000);
      // clear code selection
      e.clearSelection();
    }
    const getTextToCopy = function(trigger) {
      const outerScaffold = trigger.parentElement.cloneNode(true);
      const codeEl = outerScaffold.querySelector('code');
      for (const childEl of codeEl.children) {
        if (isCodeAnnotation(childEl)) {
          childEl.remove();
        }
      }
      return codeEl.innerText;
    }
    const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
      text: getTextToCopy
    });
    clipboard.on('success', onCopySuccess);
    if (window.document.getElementById('quarto-embedded-source-code-modal')) {
      const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
        text: getTextToCopy,
        container: window.document.getElementById('quarto-embedded-source-code-modal')
      });
      clipboardModal.on('success', onCopySuccess);
    }
    const viewSource = window.document.getElementById('quarto-view-source') ||
                       window.document.getElementById('quarto-code-tools-source');
    if (viewSource) {
      const sourceUrl = viewSource.getAttribute("data-quarto-source-url");
      viewSource.addEventListener("click", function(e) {
        if (sourceUrl) {
          // rstudio viewer pane
          if (/\bcapabilities=\b/.test(window.location)) {
            window.open(sourceUrl);
          } else {
            window.location.href = sourceUrl;
          }
        } else {
          const modal = new bootstrap.Modal(document.getElementById('quarto-embedded-source-code-modal'));
          modal.show();
        }
        return false;
      });
    }
    function toggleCodeHandler(show) {
      return function(e) {
        const detailsSrc = window.document.querySelectorAll(".cell > details > .sourceCode");
        for (let i=0; i<detailsSrc.length; i++) {
          const details = detailsSrc[i].parentElement;
          if (show) {
            details.open = true;
          } else {
            details.removeAttribute("open");
          }
        }
        const cellCodeDivs = window.document.querySelectorAll(".cell > .sourceCode");
        const fromCls = show ? "hidden" : "unhidden";
        const toCls = show ? "unhidden" : "hidden";
        for (let i=0; i<cellCodeDivs.length; i++) {
          const codeDiv = cellCodeDivs[i];
          if (codeDiv.classList.contains(fromCls)) {
            codeDiv.classList.remove(fromCls);
            codeDiv.classList.add(toCls);
          } 
        }
        return false;
      }
    }
    const hideAllCode = window.document.getElementById("quarto-hide-all-code");
    if (hideAllCode) {
      hideAllCode.addEventListener("click", toggleCodeHandler(false));
    }
    const showAllCode = window.document.getElementById("quarto-show-all-code");
    if (showAllCode) {
      showAllCode.addEventListener("click", toggleCodeHandler(true));
    }
      var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
      var mailtoRegex = new RegExp(/^mailto:/);
        var filterRegex = new RegExp('/' + window.location.host + '/');
      var isInternal = (href) => {
          return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
      }
      // Inspect non-navigation links and adorn them if external
     var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
      for (var i=0; i<links.length; i++) {
        const link = links[i];
        if (!isInternal(link.href)) {
          // undo the damage that might have been done by quarto-nav.js in the case of
          // links that we want to consider external
          if (link.dataset.originalHref !== undefined) {
            link.href = link.dataset.originalHref;
          }
            // target, if specified
            link.setAttribute("target", "_blank");
            if (link.getAttribute("rel") === null) {
              link.setAttribute("rel", "noopener");
            }
            // default icon
            link.classList.add("external");
        }
      }
    function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
      const config = {
        allowHTML: true,
        maxWidth: 500,
        delay: 100,
        arrow: false,
        appendTo: function(el) {
            return el.parentElement;
        },
        interactive: true,
        interactiveBorder: 10,
        theme: 'quarto',
        placement: 'bottom-start',
      };
      if (contentFn) {
        config.content = contentFn;
      }
      if (onTriggerFn) {
        config.onTrigger = onTriggerFn;
      }
      if (onUntriggerFn) {
        config.onUntrigger = onUntriggerFn;
      }
      window.tippy(el, config); 
    }
    const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
    for (var i=0; i<noterefs.length; i++) {
      const ref = noterefs[i];
      tippyHover(ref, function() {
        // use id or data attribute instead here
        let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
        try { href = new URL(href).hash; } catch {}
        const id = href.replace(/^#\/?/, "");
        const note = window.document.getElementById(id);
        if (note) {
          return note.innerHTML;
        } else {
          return "";
        }
      });
    }
    const xrefs = window.document.querySelectorAll('a.quarto-xref');
    const processXRef = (id, note) => {
      // Strip column container classes
      const stripColumnClz = (el) => {
        el.classList.remove("page-full", "page-columns");
        if (el.children) {
          for (const child of el.children) {
            stripColumnClz(child);
          }
        }
      }
      stripColumnClz(note)
      if (id === null || id.startsWith('sec-')) {
        // Special case sections, only their first couple elements
        const container = document.createElement("div");
        if (note.children && note.children.length > 2) {
          container.appendChild(note.children[0].cloneNode(true));
          for (let i = 1; i < note.children.length; i++) {
            const child = note.children[i];
            if (child.tagName === "P" && child.innerText === "") {
              continue;
            } else {
              container.appendChild(child.cloneNode(true));
              break;
            }
          }
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(container);
          }
          return container.innerHTML
        } else {
          if (window.Quarto?.typesetMath) {
            window.Quarto.typesetMath(note);
          }
          return note.innerHTML;
        }
      } else {
        // Remove any anchor links if they are present
        const anchorLink = note.querySelector('a.anchorjs-link');
        if (anchorLink) {
          anchorLink.remove();
        }
        if (window.Quarto?.typesetMath) {
          window.Quarto.typesetMath(note);
        }
        if (note.classList.contains("callout")) {
          return note.outerHTML;
        } else {
          return note.innerHTML;
        }
      }
    }
    for (var i=0; i<xrefs.length; i++) {
      const xref = xrefs[i];
      tippyHover(xref, undefined, function(instance) {
        instance.disable();
        let url = xref.getAttribute('href');
        let hash = undefined; 
        if (url.startsWith('#')) {
          hash = url;
        } else {
          try { hash = new URL(url).hash; } catch {}
        }
        if (hash) {
          const id = hash.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note !== null) {
            try {
              const html = processXRef(id, note.cloneNode(true));
              instance.setContent(html);
            } finally {
              instance.enable();
              instance.show();
            }
          } else {
            // See if we can fetch this
            fetch(url.split('#')[0])
            .then(res => res.text())
            .then(html => {
              const parser = new DOMParser();
              const htmlDoc = parser.parseFromString(html, "text/html");
              const note = htmlDoc.getElementById(id);
              if (note !== null) {
                const html = processXRef(id, note);
                instance.setContent(html);
              } 
            }).finally(() => {
              instance.enable();
              instance.show();
            });
          }
        } else {
          // See if we can fetch a full url (with no hash to target)
          // This is a special case and we should probably do some content thinning / targeting
          fetch(url)
          .then(res => res.text())
          .then(html => {
            const parser = new DOMParser();
            const htmlDoc = parser.parseFromString(html, "text/html");
            const note = htmlDoc.querySelector('main.content');
            if (note !== null) {
              // This should only happen for chapter cross references
              // (since there is no id in the URL)
              // remove the first header
              if (note.children.length > 0 && note.children[0].tagName === "HEADER") {
                note.children[0].remove();
              }
              const html = processXRef(null, note);
              instance.setContent(html);
            } 
          }).finally(() => {
            instance.enable();
            instance.show();
          });
        }
      }, function(instance) {
      });
    }
        let selectedAnnoteEl;
        const selectorForAnnotation = ( cell, annotation) => {
          let cellAttr = 'data-code-cell="' + cell + '"';
          let lineAttr = 'data-code-annotation="' +  annotation + '"';
          const selector = 'span[' + cellAttr + '][' + lineAttr + ']';
          return selector;
        }
        const selectCodeLines = (annoteEl) => {
          const doc = window.document;
          const targetCell = annoteEl.getAttribute("data-target-cell");
          const targetAnnotation = annoteEl.getAttribute("data-target-annotation");
          const annoteSpan = window.document.querySelector(selectorForAnnotation(targetCell, targetAnnotation));
          const lines = annoteSpan.getAttribute("data-code-lines").split(",");
          const lineIds = lines.map((line) => {
            return targetCell + "-" + line;
          })
          let top = null;
          let height = null;
          let parent = null;
          if (lineIds.length > 0) {
              //compute the position of the single el (top and bottom and make a div)
              const el = window.document.getElementById(lineIds[0]);
              top = el.offsetTop;
              height = el.offsetHeight;
              parent = el.parentElement.parentElement;
            if (lineIds.length > 1) {
              const lastEl = window.document.getElementById(lineIds[lineIds.length - 1]);
              const bottom = lastEl.offsetTop + lastEl.offsetHeight;
              height = bottom - top;
            }
            if (top !== null && height !== null && parent !== null) {
              // cook up a div (if necessary) and position it 
              let div = window.document.getElementById("code-annotation-line-highlight");
              if (div === null) {
                div = window.document.createElement("div");
                div.setAttribute("id", "code-annotation-line-highlight");
                div.style.position = 'absolute';
                parent.appendChild(div);
              }
              div.style.top = top - 2 + "px";
              div.style.height = height + 4 + "px";
              div.style.left = 0;
              let gutterDiv = window.document.getElementById("code-annotation-line-highlight-gutter");
              if (gutterDiv === null) {
                gutterDiv = window.document.createElement("div");
                gutterDiv.setAttribute("id", "code-annotation-line-highlight-gutter");
                gutterDiv.style.position = 'absolute';
                const codeCell = window.document.getElementById(targetCell);
                const gutter = codeCell.querySelector('.code-annotation-gutter');
                gutter.appendChild(gutterDiv);
              }
              gutterDiv.style.top = top - 2 + "px";
              gutterDiv.style.height = height + 4 + "px";
            }
            selectedAnnoteEl = annoteEl;
          }
        };
        const unselectCodeLines = () => {
          const elementsIds = ["code-annotation-line-highlight", "code-annotation-line-highlight-gutter"];
          elementsIds.forEach((elId) => {
            const div = window.document.getElementById(elId);
            if (div) {
              div.remove();
            }
          });
          selectedAnnoteEl = undefined;
        };
          // Handle positioning of the toggle
      window.addEventListener(
        "resize",
        throttle(() => {
          elRect = undefined;
          if (selectedAnnoteEl) {
            selectCodeLines(selectedAnnoteEl);
          }
        }, 10)
      );
      function throttle(fn, ms) {
      let throttle = false;
      let timer;
        return (...args) => {
          if(!throttle) { // first call gets through
              fn.apply(this, args);
              throttle = true;
          } else { // all the others get throttled
              if(timer) clearTimeout(timer); // cancel #2
              timer = setTimeout(() => {
                fn.apply(this, args);
                timer = throttle = false;
              }, ms);
          }
        };
      }
        // Attach click handler to the DT
        const annoteDls = window.document.querySelectorAll('dt[data-target-cell]');
        for (const annoteDlNode of annoteDls) {
          annoteDlNode.addEventListener('click', (event) => {
            const clickedEl = event.target;
            if (clickedEl !== selectedAnnoteEl) {
              unselectCodeLines();
              const activeEl = window.document.querySelector('dt[data-target-cell].code-annotation-active');
              if (activeEl) {
                activeEl.classList.remove('code-annotation-active');
              }
              selectCodeLines(clickedEl);
              clickedEl.classList.add('code-annotation-active');
            } else {
              // Unselect the line
              unselectCodeLines();
              clickedEl.classList.remove('code-annotation-active');
            }
          });
        }
    const findCites = (el) => {
      const parentEl = el.parentElement;
      if (parentEl) {
        const cites = parentEl.dataset.cites;
        if (cites) {
          return {
            el,
            cites: cites.split(' ')
          };
        } else {
          return findCites(el.parentElement)
        }
      } else {
        return undefined;
      }
    };
    var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
    for (var i=0; i<bibliorefs.length; i++) {
      const ref = bibliorefs[i];
      const citeInfo = findCites(ref);
      if (citeInfo) {
        tippyHover(citeInfo.el, function() {
          var popup = window.document.createElement('div');
          citeInfo.cites.forEach(function(cite) {
            var citeDiv = window.document.createElement('div');
            citeDiv.classList.add('hanging-indent');
            citeDiv.classList.add('csl-entry');
            var biblioDiv = window.document.getElementById('ref-' + cite);
            if (biblioDiv) {
              citeDiv.innerHTML = biblioDiv.innerHTML;
            }
            popup.appendChild(citeDiv);
          });
          return popup.innerHTML;
        });
      }
    }
  });
  </script><div class="modal fade" id="quarto-embedded-source-code-modal" tabindex="-1" aria-labelledby="quarto-embedded-source-code-modal-label" aria-hidden="true"><div class="modal-dialog modal-dialog-scrollable"><div class="modal-content"><div class="modal-header"><h5 class="modal-title" id="quarto-embedded-source-code-modal-label">Source Code</h5><button class="btn-close" data-bs-dismiss="modal"></button></div><div class="modal-body"><div class="">
<div class="code-copy-outer-scaffold"><div class="sourceCode" id="cb1" data-shortcodes="false"><pre class="sourceCode markdown code-with-copy"><code class="sourceCode markdown"><span id="cb1-1"><a href="#cb1-1" aria-hidden="true" tabindex="-1"></a><span class="co">---</span></span>
<span id="cb1-2"><a href="#cb1-2" aria-hidden="true" tabindex="-1"></a><span class="an">title:</span><span class="co"> "Trends &amp; Insights"</span></span>
<span id="cb1-3"><a href="#cb1-3" aria-hidden="true" tabindex="-1"></a><span class="an">subtitle:</span><span class="co"> "Key themes and future directions from R/Pharma 2025"</span></span>
<span id="cb1-4"><a href="#cb1-4" aria-hidden="true" tabindex="-1"></a><span class="an">toc:</span><span class="co"> true</span></span>
<span id="cb1-5"><a href="#cb1-5" aria-hidden="true" tabindex="-1"></a><span class="co">---</span></span>
<span id="cb1-6"><a href="#cb1-6" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-7"><a href="#cb1-7" aria-hidden="true" tabindex="-1"></a><span class="fu">## Executive Summary</span></span>
<span id="cb1-8"><a href="#cb1-8" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-9"><a href="#cb1-9" aria-hidden="true" tabindex="-1"></a>R/Pharma 2025 marked a pivotal moment in pharmaceutical R adoption, with three dominant themes emerging: **AI/LLM integration**, **open-source transformation**, and **regulatory acceptance**. The conference showcased 19 workshops and 30+ presentations revealing an industry in rapid transition from proprietary tools to collaborative, standards-based approaches.</span>
<span id="cb1-10"><a href="#cb1-10" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-11"><a href="#cb1-11" aria-hidden="true" tabindex="-1"></a>**Key Statistics:**</span>
<span id="cb1-12"><a href="#cb1-12" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-13"><a href="#cb1-13" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>ü§ñ **8+ sessions** on AI/LLM (50% increase from previous years)</span>
<span id="cb1-14"><a href="#cb1-14" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üìä **GSK achieved 50%+ R code** across Biostatistics</span>
<span id="cb1-15"><a href="#cb1-15" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ **FDA neutrality** on statistical software increasingly normalized</span>
<span id="cb1-16"><a href="#cb1-16" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üåê **CDISC ARS/ARM** driving automation and standardization</span>
<span id="cb1-17"><a href="#cb1-17" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-18"><a href="#cb1-18" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-19"><a href="#cb1-19" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-20"><a href="#cb1-20" aria-hidden="true" tabindex="-1"></a><span class="fu">## 1. The AI/LLM Revolution ü§ñ</span></span>
<span id="cb1-21"><a href="#cb1-21" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-22"><a href="#cb1-22" aria-hidden="true" tabindex="-1"></a><span class="fu">### Emergence as Dominant Theme</span></span>
<span id="cb1-23"><a href="#cb1-23" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-24"><a href="#cb1-24" aria-hidden="true" tabindex="-1"></a>AI and Large Language Models were the most discussed topic, appearing in:</span>
<span id="cb1-25"><a href="#cb1-25" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-26"><a href="#cb1-26" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**3 dedicated workshops** (ellmer basics, enterprise tooling, clinical data privacy)</span>
<span id="cb1-27"><a href="#cb1-27" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**8+ presentations** across all sessions</span>
<span id="cb1-28"><a href="#cb1-28" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Multiple vendor tools** ({ellmer}, {llumen}, {mcpr}, Databot, {meRlin})</span>
<span id="cb1-29"><a href="#cb1-29" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-30"><a href="#cb1-30" aria-hidden="true" tabindex="-1"></a><span class="fu">### From Prototype to Production</span></span>
<span id="cb1-31"><a href="#cb1-31" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-32"><a href="#cb1-32" aria-hidden="true" tabindex="-1"></a>The conversation has matured from "Can we use AI?" to "How do we deploy it safely?"</span>
<span id="cb1-33"><a href="#cb1-33" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-34"><a href="#cb1-34" aria-hidden="true" tabindex="-1"></a>**Key Developments:**</span>
<span id="cb1-35"><a href="#cb1-35" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-36"><a href="#cb1-36" aria-hidden="true" tabindex="-1"></a><span class="fu">#### 1. **Enterprise-Ready Frameworks**</span></span>
<span id="cb1-37"><a href="#cb1-37" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-38"><a href="#cb1-38" aria-hidden="true" tabindex="-1"></a>Organizations are building production AI systems:</span>
<span id="cb1-39"><a href="#cb1-39" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-40"><a href="#cb1-40" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Merck's {llumen}** - Comprehensive agentic framework used internally</span>
<span id="cb1-41"><a href="#cb1-41" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Supports multiple LLM sources (Azure, OpenAI, local)</span>
<span id="cb1-42"><a href="#cb1-42" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>RAG with vector databases for documents</span>
<span id="cb1-43"><a href="#cb1-43" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Database querying (SQL, Cypher, GraphQL)</span>
<span id="cb1-44"><a href="#cb1-44" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Foundation model integration (TxGemma)</span>
<span id="cb1-45"><a href="#cb1-45" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Roche's Multi-Agent Copilot** - Package-specific AI agents</span>
<span id="cb1-46"><a href="#cb1-46" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Each internal package gets its own expert agent</span>
<span id="cb1-47"><a href="#cb1-47" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>LangGraph orchestration</span>
<span id="cb1-48"><a href="#cb1-48" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Integration with Cursor via MCP</span>
<span id="cb1-49"><a href="#cb1-49" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**A2-AI's GxP Solutions** - Validated AI workflows</span>
<span id="cb1-50"><a href="#cb1-50" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>AWS Bedrock integration</span>
<span id="cb1-51"><a href="#cb1-51" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>MCP server implementations</span>
<span id="cb1-52"><a href="#cb1-52" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Compliance documentation</span>
<span id="cb1-53"><a href="#cb1-53" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-54"><a href="#cb1-54" aria-hidden="true" tabindex="-1"></a><span class="fu">#### 2. **Privacy-Preserving Approaches**</span></span>
<span id="cb1-55"><a href="#cb1-55" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-56"><a href="#cb1-56" aria-hidden="true" tabindex="-1"></a>Critical for pharma with sensitive clinical data:</span>
<span id="cb1-57"><a href="#cb1-57" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-58"><a href="#cb1-58" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**On-premise LLM deployments** (llama.cpp)</span>
<span id="cb1-59"><a href="#cb1-59" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Query sanitization** removing PII</span>
<span id="cb1-60"><a href="#cb1-60" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Audit logging** for compliance</span>
<span id="cb1-61"><a href="#cb1-61" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Role-based access** controls</span>
<span id="cb1-62"><a href="#cb1-62" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**{DataChat} example** - Chat interface with data never leaving secure environment</span>
<span id="cb1-63"><a href="#cb1-63" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-64"><a href="#cb1-64" aria-hidden="true" tabindex="-1"></a><span class="fu">#### 3. **Practical Applications**</span></span>
<span id="cb1-65"><a href="#cb1-65" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-66"><a href="#cb1-66" aria-hidden="true" tabindex="-1"></a>Moving beyond novelty to genuine productivity:</span>
<span id="cb1-67"><a href="#cb1-67" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-68"><a href="#cb1-68" aria-hidden="true" tabindex="-1"></a>**Data Exploration:**</span>
<span id="cb1-69"><a href="#cb1-69" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-70"><a href="#cb1-70" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Natural language queries on CDISC data</span>
<span id="cb1-71"><a href="#cb1-71" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Conversational interfaces for non-programmers</span>
<span id="cb1-72"><a href="#cb1-72" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>RAG-powered document search</span>
<span id="cb1-73"><a href="#cb1-73" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-74"><a href="#cb1-74" aria-hidden="true" tabindex="-1"></a>**Code Assistance:**</span>
<span id="cb1-75"><a href="#cb1-75" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-76"><a href="#cb1-76" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Context-aware programming help</span>
<span id="cb1-77"><a href="#cb1-77" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Debugging complex statistical code</span>
<span id="cb1-78"><a href="#cb1-78" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Documentation generation</span>
<span id="cb1-79"><a href="#cb1-79" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-80"><a href="#cb1-80" aria-hidden="true" tabindex="-1"></a>**Report Automation:**</span>
<span id="cb1-81"><a href="#cb1-81" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-82"><a href="#cb1-82" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>LLM-powered table summarization</span>
<span id="cb1-83"><a href="#cb1-83" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Narrative generation from results</span>
<span id="cb1-84"><a href="#cb1-84" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>QC log generation</span>
<span id="cb1-85"><a href="#cb1-85" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-86"><a href="#cb1-86" aria-hidden="true" tabindex="-1"></a><span class="fu">### Standards Emerging</span></span>
<span id="cb1-87"><a href="#cb1-87" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-88"><a href="#cb1-88" aria-hidden="true" tabindex="-1"></a>**Model Context Protocol (MCP):**</span>
<span id="cb1-89"><a href="#cb1-89" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-90"><a href="#cb1-90" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Standardized interface for AI tools</span>
<span id="cb1-91"><a href="#cb1-91" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>R implementation via {mcpr}</span>
<span id="cb1-92"><a href="#cb1-92" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Cross-language interoperability</span>
<span id="cb1-93"><a href="#cb1-93" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Growing ecosystem (Claude Code, Cursor, VS Code)</span>
<span id="cb1-94"><a href="#cb1-94" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-95"><a href="#cb1-95" aria-hidden="true" tabindex="-1"></a><span class="fu">### Challenges Identified</span></span>
<span id="cb1-96"><a href="#cb1-96" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-97"><a href="#cb1-97" aria-hidden="true" tabindex="-1"></a>Despite enthusiasm, several barriers remain:</span>
<span id="cb1-98"><a href="#cb1-98" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-99"><a href="#cb1-99" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚ö†Ô∏è **Validation complexity** - How to validate non-deterministic outputs</span>
<span id="cb1-100"><a href="#cb1-100" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚ö†Ô∏è **Cost management** - API costs at scale</span>
<span id="cb1-101"><a href="#cb1-101" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚ö†Ô∏è **Regulatory uncertainty** - Limited guidance on AI in submissions</span>
<span id="cb1-102"><a href="#cb1-102" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚ö†Ô∏è **Skills gap** - Prompt engineering and AI orchestration expertise</span>
<span id="cb1-103"><a href="#cb1-103" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-104"><a href="#cb1-104" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-105"><a href="#cb1-105" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-106"><a href="#cb1-106" aria-hidden="true" tabindex="-1"></a><span class="fu">## 2. Open-Source Transformation üåê</span></span>
<span id="cb1-107"><a href="#cb1-107" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-108"><a href="#cb1-108" aria-hidden="true" tabindex="-1"></a><span class="fu">### GSK's Landmark Achievement</span></span>
<span id="cb1-109"><a href="#cb1-109" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-110"><a href="#cb1-110" aria-hidden="true" tabindex="-1"></a>**Sam Warden's** presentation on GSK's journey was a conference highlight:</span>
<span id="cb1-111"><a href="#cb1-111" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-112"><a href="#cb1-112" aria-hidden="true" tabindex="-1"></a>**Timeline:**</span>
<span id="cb1-113"><a href="#cb1-113" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-114"><a href="#cb1-114" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**2018-2020:** Pilot programs and early adopters</span>
<span id="cb1-115"><a href="#cb1-115" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**2020-2022:** COVID acceleration and platform adoption</span>
<span id="cb1-116"><a href="#cb1-116" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**2023-2024:** 50%+ R code target **achieved**</span>
<span id="cb1-117"><a href="#cb1-117" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**2025:** Rburst initiative for full integration</span>
<span id="cb1-118"><a href="#cb1-118" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-119"><a href="#cb1-119" aria-hidden="true" tabindex="-1"></a>**Success Factors:**</span>
<span id="cb1-120"><a href="#cb1-120" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-121"><a href="#cb1-121" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**Executive commitment** - Clear target setting (50%+ R)</span>
<span id="cb1-122"><a href="#cb1-122" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**Multi-wave approach** - Gradual transformation</span>
<span id="cb1-123"><a href="#cb1-123" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**Training investment** - Bookdown courses, Resource Hub, AccelerateR</span>
<span id="cb1-124"><a href="#cb1-124" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**Platform deployment** - Posit Workbench for infrastructure</span>
<span id="cb1-125"><a href="#cb1-125" aria-hidden="true" tabindex="-1"></a><span class="ss">5.  </span>**Cultural change** - Growth mindset and adaptability</span>
<span id="cb1-126"><a href="#cb1-126" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-127"><a href="#cb1-127" aria-hidden="true" tabindex="-1"></a><span class="fu">### Industry-Wide Movement</span></span>
<span id="cb1-128"><a href="#cb1-128" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-129"><a href="#cb1-129" aria-hidden="true" tabindex="-1"></a>GSK is not alone - the tipping point has been reached:</span>
<span id="cb1-130"><a href="#cb1-130" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-131"><a href="#cb1-131" aria-hidden="true" tabindex="-1"></a>**Novartis:**</span>
<span id="cb1-132"><a href="#cb1-132" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-133"><a href="#cb1-133" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Mosaic platform for ARS-driven TFL automation</span>
<span id="cb1-134"><a href="#cb1-134" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Standards-based, language-agnostic approach</span>
<span id="cb1-135"><a href="#cb1-135" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>React UI with R backend</span>
<span id="cb1-136"><a href="#cb1-136" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-137"><a href="#cb1-137" aria-hidden="true" tabindex="-1"></a>**Roche/Genentech:**</span>
<span id="cb1-138"><a href="#cb1-138" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-139"><a href="#cb1-139" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Leading {admiral}, {teal}, {gtsummary} development</span>
<span id="cb1-140"><a href="#cb1-140" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>autoslideR for slide automation</span>
<span id="cb1-141"><a href="#cb1-141" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>{crane} for pharma-specific reporting</span>
<span id="cb1-142"><a href="#cb1-142" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-143"><a href="#cb1-143" aria-hidden="true" tabindex="-1"></a>**Pfizer:**</span>
<span id="cb1-144"><a href="#cb1-144" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-145"><a href="#cb1-145" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Custom R packages for RWD programming</span>
<span id="cb1-146"><a href="#cb1-146" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Dual R/SAS syntax support</span>
<span id="cb1-147"><a href="#cb1-147" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Quarto documentation sites</span>
<span id="cb1-148"><a href="#cb1-148" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-149"><a href="#cb1-149" aria-hidden="true" tabindex="-1"></a>**Moderna:**</span>
<span id="cb1-150"><a href="#cb1-150" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-151"><a href="#cb1-151" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>AI-enhanced Shiny apps for trial data</span>
<span id="cb1-152"><a href="#cb1-152" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>ellmer/GPT integration</span>
<span id="cb1-153"><a href="#cb1-153" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Accelerating exploratory analysis</span>
<span id="cb1-154"><a href="#cb1-154" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-155"><a href="#cb1-155" aria-hidden="true" tabindex="-1"></a><span class="fu">### Pharmaverse Ecosystem</span></span>
<span id="cb1-156"><a href="#cb1-156" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-157"><a href="#cb1-157" aria-hidden="true" tabindex="-1"></a>The collaborative open-source movement is thriving:</span>
<span id="cb1-158"><a href="#cb1-158" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-159"><a href="#cb1-159" aria-hidden="true" tabindex="-1"></a>**Key Packages:**</span>
<span id="cb1-160"><a href="#cb1-160" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-161"><a href="#cb1-161" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**{admiral}** - Transitioning to stable maintenance (feature complete)</span>
<span id="cb1-162"><a href="#cb1-162" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**{teal}** - Version 1.0 released (interactive apps)</span>
<span id="cb1-163"><a href="#cb1-163" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**{gtsummary}/{crane}** - Clinical table generation</span>
<span id="cb1-164"><a href="#cb1-164" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**{cardinal}** - Standardized TLG templates</span>
<span id="cb1-165"><a href="#cb1-165" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**{sdtm.oak}** - SDTM programming framework</span>
<span id="cb1-166"><a href="#cb1-166" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-167"><a href="#cb1-167" aria-hidden="true" tabindex="-1"></a>**Benefits Realized:**</span>
<span id="cb1-168"><a href="#cb1-168" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-169"><a href="#cb1-169" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Reduced duplication across companies</span>
<span id="cb1-170"><a href="#cb1-170" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Shared validation burden</span>
<span id="cb1-171"><a href="#cb1-171" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Faster innovation cycles</span>
<span id="cb1-172"><a href="#cb1-172" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Transparent, auditable code</span>
<span id="cb1-173"><a href="#cb1-173" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-174"><a href="#cb1-174" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-175"><a href="#cb1-175" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-176"><a href="#cb1-176" aria-hidden="true" tabindex="-1"></a><span class="fu">## 3. Regulatory Evolution ‚úÖ</span></span>
<span id="cb1-177"><a href="#cb1-177" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-178"><a href="#cb1-178" aria-hidden="true" tabindex="-1"></a><span class="fu">### FDA Software Neutrality</span></span>
<span id="cb1-179"><a href="#cb1-179" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-180"><a href="#cb1-180" aria-hidden="true" tabindex="-1"></a>The 2015 FDA clarification on software neutrality is now **fully operationalized**:</span>
<span id="cb1-181"><a href="#cb1-181" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-182"><a href="#cb1-182" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>No preference for SAS vs R vs Python</span>
<span id="cb1-183"><a href="#cb1-183" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Focus on **methodology** and **validation**, not tools</span>
<span id="cb1-184"><a href="#cb1-184" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>R-based submissions increasingly routine</span>
<span id="cb1-185"><a href="#cb1-185" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-186"><a href="#cb1-186" aria-hidden="true" tabindex="-1"></a><span class="fu">### New FDA Guidance Impact</span></span>
<span id="cb1-187"><a href="#cb1-187" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-188"><a href="#cb1-188" aria-hidden="true" tabindex="-1"></a>**2023 Covariate Adjustment Guidance** driving change:</span>
<span id="cb1-189"><a href="#cb1-189" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-190"><a href="#cb1-190" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Novartis developed {beeca} in response</span>
<span id="cb1-191"><a href="#cb1-191" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>ASA-BIOP collaboration on {RobinCar2}</span>
<span id="cb1-192"><a href="#cb1-192" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Academic methods reaching practice faster</span>
<span id="cb1-193"><a href="#cb1-193" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>R enabling rapid response to guidance</span>
<span id="cb1-194"><a href="#cb1-194" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-195"><a href="#cb1-195" aria-hidden="true" tabindex="-1"></a><span class="fu">### Validation Maturity</span></span>
<span id="cb1-196"><a href="#cb1-196" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-197"><a href="#cb1-197" aria-hidden="true" tabindex="-1"></a>**Key Developments:**</span>
<span id="cb1-198"><a href="#cb1-198" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-199"><a href="#cb1-199" aria-hidden="true" tabindex="-1"></a><span class="fu">#### 1. **Risk-Based Approaches**</span></span>
<span id="cb1-200"><a href="#cb1-200" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-201"><a href="#cb1-201" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>{riskmetric} for package assessment</span>
<span id="cb1-202"><a href="#cb1-202" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Shared metric repositories (R Validation Hub)</span>
<span id="cb1-203"><a href="#cb1-203" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Automated quality scoring</span>
<span id="cb1-204"><a href="#cb1-204" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Focus on critical packages</span>
<span id="cb1-205"><a href="#cb1-205" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-206"><a href="#cb1-206" aria-hidden="true" tabindex="-1"></a><span class="fu">#### 2. **Acceptance-Test Driven Development (ATDD)**</span></span>
<span id="cb1-207"><a href="#cb1-207" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-208"><a href="#cb1-208" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Plain-language tests in Quarto</span>
<span id="cb1-209"><a href="#cb1-209" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Shareable with regulators</span>
<span id="cb1-210"><a href="#cb1-210" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>"Given-when-then" format</span>
<span id="cb1-211"><a href="#cb1-211" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Brian Repko bringing JBehave concepts to R</span>
<span id="cb1-212"><a href="#cb1-212" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-213"><a href="#cb1-213" aria-hidden="true" tabindex="-1"></a><span class="fu">#### 3. **Shiny App Validation**</span></span>
<span id="cb1-214"><a href="#cb1-214" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-215"><a href="#cb1-215" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Litmusverse suite (Jumping Rivers)</span>
<span id="cb1-216"><a href="#cb1-216" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Risk-based validation frameworks</span>
<span id="cb1-217"><a href="#cb1-217" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Code quality assessment</span>
<span id="cb1-218"><a href="#cb1-218" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Traceability and documentation tools</span>
<span id="cb1-219"><a href="#cb1-219" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-220"><a href="#cb1-220" aria-hidden="true" tabindex="-1"></a><span class="fu">### GxP-Ready AI</span></span>
<span id="cb1-221"><a href="#cb1-221" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-222"><a href="#cb1-222" aria-hidden="true" tabindex="-1"></a>Pioneering work on validating AI applications:</span>
<span id="cb1-223"><a href="#cb1-223" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-224"><a href="#cb1-224" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Devin Pastoor (A2-AI):** Production AI in GxP contexts</span>
<span id="cb1-225"><a href="#cb1-225" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Testing strategies for non-deterministic outputs</span>
<span id="cb1-226"><a href="#cb1-226" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Audit trails and logging</span>
<span id="cb1-227"><a href="#cb1-227" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Version control and rollback procedures</span>
<span id="cb1-228"><a href="#cb1-228" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-229"><a href="#cb1-229" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-230"><a href="#cb1-230" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-231"><a href="#cb1-231" aria-hidden="true" tabindex="-1"></a><span class="fu">## 4. Automation &amp; Efficiency üìä</span></span>
<span id="cb1-232"><a href="#cb1-232" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-233"><a href="#cb1-233" aria-hidden="true" tabindex="-1"></a><span class="fu">### ARS/ARM as Game Changers</span></span>
<span id="cb1-234"><a href="#cb1-234" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-235"><a href="#cb1-235" aria-hidden="true" tabindex="-1"></a>**CDISC Analysis Results Standard** driving automation:</span>
<span id="cb1-236"><a href="#cb1-236" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-237"><a href="#cb1-237" aria-hidden="true" tabindex="-1"></a>**Mosaic (Novartis):**</span>
<span id="cb1-238"><a href="#cb1-238" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-239"><a href="#cb1-239" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>YAML captures ARD requirements</span>
<span id="cb1-240"><a href="#cb1-240" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Language-agnostic rules (metadata ‚Üí R or any language)</span>
<span id="cb1-241"><a href="#cb1-241" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>React UI for customization</span>
<span id="cb1-242"><a href="#cb1-242" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Push-button TFL generation</span>
<span id="cb1-243"><a href="#cb1-243" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-244"><a href="#cb1-244" aria-hidden="true" tabindex="-1"></a>**{cards} Ecosystem:**</span>
<span id="cb1-245"><a href="#cb1-245" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-246"><a href="#cb1-246" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Analysis Results Data objects</span>
<span id="cb1-247"><a href="#cb1-247" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>QC becomes straightforward (compare ARDs)</span>
<span id="cb1-248"><a href="#cb1-248" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>LLMs can summarize language-agnostic results</span>
<span id="cb1-249"><a href="#cb1-249" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>{crane} and {gtsummary} building on this foundation</span>
<span id="cb1-250"><a href="#cb1-250" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-251"><a href="#cb1-251" aria-hidden="true" tabindex="-1"></a><span class="fu">### Report Automation</span></span>
<span id="cb1-252"><a href="#cb1-252" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-253"><a href="#cb1-253" aria-hidden="true" tabindex="-1"></a>**Time Savings Achieved:**</span>
<span id="cb1-254"><a href="#cb1-254" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-255"><a href="#cb1-255" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**autoslideR (Roche):** 0.5-4 days per slide deck</span>
<span id="cb1-256"><a href="#cb1-256" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**DMC materials automation:** Week ‚Üí Day for exposure reports (AstraZeneca)</span>
<span id="cb1-257"><a href="#cb1-257" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**LLM-powered {gtsummary}:** Submission-ready tables in minutes vs hours</span>
<span id="cb1-258"><a href="#cb1-258" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-259"><a href="#cb1-259" aria-hidden="true" tabindex="-1"></a>**Technologies Enabling This:**</span>
<span id="cb1-260"><a href="#cb1-260" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-261"><a href="#cb1-261" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**officer/flextable** - Programmatic Word reports</span>
<span id="cb1-262"><a href="#cb1-262" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**Quarto** - Multi-format publishing (PDF, HTML, presentations)</span>
<span id="cb1-263"><a href="#cb1-263" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**Template systems** - Reusable structures (Cardinal)</span>
<span id="cb1-264"><a href="#cb1-264" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**CI/CD pipelines** - Automated reanalysis on code changes</span>
<span id="cb1-265"><a href="#cb1-265" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-266"><a href="#cb1-266" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-267"><a href="#cb1-267" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-268"><a href="#cb1-268" aria-hidden="true" tabindex="-1"></a><span class="fu">## 5. Advanced Analytics &amp; Methods üìà</span></span>
<span id="cb1-269"><a href="#cb1-269" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-270"><a href="#cb1-270" aria-hidden="true" tabindex="-1"></a><span class="fu">### Bayesian Methods Maturing</span></span>
<span id="cb1-271"><a href="#cb1-271" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-272"><a href="#cb1-272" aria-hidden="true" tabindex="-1"></a>**Tools Reaching Production:**</span>
<span id="cb1-273"><a href="#cb1-273" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-274"><a href="#cb1-274" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**BayesERtools** (Genentech) - Exposure-response with Stan</span>
<span id="cb1-275"><a href="#cb1-275" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**bmstate** (Generable) - Multistate survival models</span>
<span id="cb1-276"><a href="#cb1-276" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Stan debugging workshop** - Making Bayesian accessible</span>
<span id="cb1-277"><a href="#cb1-277" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-278"><a href="#cb1-278" aria-hidden="true" tabindex="-1"></a>**Advantages in Pharma:**</span>
<span id="cb1-279"><a href="#cb1-279" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-280"><a href="#cb1-280" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Prior information integration</span>
<span id="cb1-281"><a href="#cb1-281" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Uncertainty quantification</span>
<span id="cb1-282"><a href="#cb1-282" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Small sample performance</span>
<span id="cb1-283"><a href="#cb1-283" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Complex model flexibility</span>
<span id="cb1-284"><a href="#cb1-284" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-285"><a href="#cb1-285" aria-hidden="true" tabindex="-1"></a><span class="fu">### High-Performance Computing</span></span>
<span id="cb1-286"><a href="#cb1-286" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-287"><a href="#cb1-287" aria-hidden="true" tabindex="-1"></a>**Polars for Clinical Data:**</span>
<span id="cb1-288"><a href="#cb1-288" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-289"><a href="#cb1-289" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>10-100x faster than pandas</span>
<span id="cb1-290"><a href="#cb1-290" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Apache Arrow native</span>
<span id="cb1-291"><a href="#cb1-291" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Lazy evaluation</span>
<span id="cb1-292"><a href="#cb1-292" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Parallel processing out-of-the-box</span>
<span id="cb1-293"><a href="#cb1-293" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-294"><a href="#cb1-294" aria-hidden="true" tabindex="-1"></a>**HPC Integration:**</span>
<span id="cb1-295"><a href="#cb1-295" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-296"><a href="#cb1-296" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Offloading Shiny computations to clusters</span>
<span id="cb1-297"><a href="#cb1-297" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Maintaining interactive UX</span>
<span id="cb1-298"><a href="#cb1-298" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Resource optimization</span>
<span id="cb1-299"><a href="#cb1-299" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-300"><a href="#cb1-300" aria-hidden="true" tabindex="-1"></a><span class="fu">### Machine Learning</span></span>
<span id="cb1-301"><a href="#cb1-301" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-302"><a href="#cb1-302" aria-hidden="true" tabindex="-1"></a>**TabPFN** - Novel deep learning for tabular data:</span>
<span id="cb1-303"><a href="#cb1-303" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-304"><a href="#cb1-304" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>No training required (pre-trained on priors)</span>
<span id="cb1-305"><a href="#cb1-305" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Fast inference</span>
<span id="cb1-306"><a href="#cb1-306" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Bayesian-like uncertainty</span>
<span id="cb1-307"><a href="#cb1-307" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Promising for exploratory analysis</span>
<span id="cb1-308"><a href="#cb1-308" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-309"><a href="#cb1-309" aria-hidden="true" tabindex="-1"></a>**Synthetic Data:**</span>
<span id="cb1-310"><a href="#cb1-310" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-311"><a href="#cb1-311" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>{synthpop} for privacy-preserving data sharing</span>
<span id="cb1-312"><a href="#cb1-312" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Software testing without PHI</span>
<span id="cb1-313"><a href="#cb1-313" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Model training on synthetic patients</span>
<span id="cb1-314"><a href="#cb1-314" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-315"><a href="#cb1-315" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-316"><a href="#cb1-316" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-317"><a href="#cb1-317" aria-hidden="true" tabindex="-1"></a><span class="fu">## 6. Data Quality &amp; Validation üîç</span></span>
<span id="cb1-318"><a href="#cb1-318" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-319"><a href="#cb1-319" aria-hidden="true" tabindex="-1"></a><span class="fu">### {pointblank} Adoption</span></span>
<span id="cb1-320"><a href="#cb1-320" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-321"><a href="#cb1-321" aria-hidden="true" tabindex="-1"></a>Comprehensive data validation framework:</span>
<span id="cb1-322"><a href="#cb1-322" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-323"><a href="#cb1-323" aria-hidden="true" tabindex="-1"></a>**Use Cases:**</span>
<span id="cb1-324"><a href="#cb1-324" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-325"><a href="#cb1-325" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Quick dataset understanding (<span class="in">`scan_data()`</span>)</span>
<span id="cb1-326"><a href="#cb1-326" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Validation at scale (35+ tables daily)</span>
<span id="cb1-327"><a href="#cb1-327" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Beautiful automated documentation</span>
<span id="cb1-328"><a href="#cb1-328" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Integration with databases, Arrow, Shiny</span>
<span id="cb1-329"><a href="#cb1-329" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-330"><a href="#cb1-330" aria-hidden="true" tabindex="-1"></a>**Pharmaceutical Applications:**</span>
<span id="cb1-331"><a href="#cb1-331" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-332"><a href="#cb1-332" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>SDTM compliance checks</span>
<span id="cb1-333"><a href="#cb1-333" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>ADaM dataset verification</span>
<span id="cb1-334"><a href="#cb1-334" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Cross-domain consistency</span>
<span id="cb1-335"><a href="#cb1-335" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Longitudinal data integrity</span>
<span id="cb1-336"><a href="#cb1-336" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-337"><a href="#cb1-337" aria-hidden="true" tabindex="-1"></a><span class="fu">### Automated Traceability</span></span>
<span id="cb1-338"><a href="#cb1-338" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-339"><a href="#cb1-339" aria-hidden="true" tabindex="-1"></a>**DevOps Principles in Pharma:**</span>
<span id="cb1-340"><a href="#cb1-340" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-341"><a href="#cb1-341" aria-hidden="true" tabindex="-1"></a>Graticule's approach:</span>
<span id="cb1-342"><a href="#cb1-342" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-343"><a href="#cb1-343" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Docker containers for reproducibility</span>
<span id="cb1-344"><a href="#cb1-344" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>CI/CD for automatic reanalysis</span>
<span id="cb1-345"><a href="#cb1-345" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Version control with validated outputs</span>
<span id="cb1-346"><a href="#cb1-346" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Cloud storage (AWS S3) for results</span>
<span id="cb1-347"><a href="#cb1-347" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-348"><a href="#cb1-348" aria-hidden="true" tabindex="-1"></a>**Benefits:**</span>
<span id="cb1-349"><a href="#cb1-349" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-350"><a href="#cb1-350" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Clear audit trail</span>
<span id="cb1-351"><a href="#cb1-351" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Reproducible analyses</span>
<span id="cb1-352"><a href="#cb1-352" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Automated documentation</span>
<span id="cb1-353"><a href="#cb1-353" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Integrated QC</span>
<span id="cb1-354"><a href="#cb1-354" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-355"><a href="#cb1-355" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-356"><a href="#cb1-356" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-357"><a href="#cb1-357" aria-hidden="true" tabindex="-1"></a><span class="fu">## 7. Specialized Applications üß¨</span></span>
<span id="cb1-358"><a href="#cb1-358" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-359"><a href="#cb1-359" aria-hidden="true" tabindex="-1"></a><span class="fu">### Real-World Evidence</span></span>
<span id="cb1-360"><a href="#cb1-360" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-361"><a href="#cb1-361" aria-hidden="true" tabindex="-1"></a>**Pfizer's RWD Programming:**</span>
<span id="cb1-362"><a href="#cb1-362" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-363"><a href="#cb1-363" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Custom R package for database queries</span>
<span id="cb1-364"><a href="#cb1-364" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Dual R/SAS syntax support</span>
<span id="cb1-365"><a href="#cb1-365" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Shiny apps for workflow support</span>
<span id="cb1-366"><a href="#cb1-366" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Quarto documentation</span>
<span id="cb1-367"><a href="#cb1-367" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-368"><a href="#cb1-368" aria-hidden="true" tabindex="-1"></a><span class="fu">### Niche Medical Devices</span></span>
<span id="cb1-369"><a href="#cb1-369" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-370"><a href="#cb1-370" aria-hidden="true" tabindex="-1"></a>**Abbott's Synthetic Data:**</span>
<span id="cb1-371"><a href="#cb1-371" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-372"><a href="#cb1-372" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>{synthpop} for diagnostics</span>
<span id="cb1-373"><a href="#cb1-373" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Privacy-preserving test data</span>
<span id="cb1-374"><a href="#cb1-374" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Validation datasets</span>
<span id="cb1-375"><a href="#cb1-375" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-376"><a href="#cb1-376" aria-hidden="true" tabindex="-1"></a><span class="fu">### Oncology Innovations</span></span>
<span id="cb1-377"><a href="#cb1-377" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-378"><a href="#cb1-378" aria-hidden="true" tabindex="-1"></a>**PMDA Inquiries:**</span>
<span id="cb1-379"><a href="#cb1-379" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-380"><a href="#cb1-380" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>{cards} for rapid response (Japan regulatory)</span>
<span id="cb1-381"><a href="#cb1-381" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Structured ARD approach</span>
<span id="cb1-382"><a href="#cb1-382" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Accelerated turnaround</span>
<span id="cb1-383"><a href="#cb1-383" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-384"><a href="#cb1-384" aria-hidden="true" tabindex="-1"></a><span class="fu">### Pharmacokinetics</span></span>
<span id="cb1-385"><a href="#cb1-385" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-386"><a href="#cb1-386" aria-hidden="true" tabindex="-1"></a>**aNCA (Pharmaverse):**</span>
<span id="cb1-387"><a href="#cb1-387" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-388"><a href="#cb1-388" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Open-source NCA software</span>
<span id="cb1-389"><a href="#cb1-389" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>PKNCA backend (200+ parameters)</span>
<span id="cb1-390"><a href="#cb1-390" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>100% test coverage</span>
<span id="cb1-391"><a href="#cb1-391" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Validated against commercial tools (¬±0.1%)</span>
<span id="cb1-392"><a href="#cb1-392" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-393"><a href="#cb1-393" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-394"><a href="#cb1-394" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-395"><a href="#cb1-395" aria-hidden="true" tabindex="-1"></a><span class="fu">## 8. Regional Insights üåè</span></span>
<span id="cb1-396"><a href="#cb1-396" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-397"><a href="#cb1-397" aria-hidden="true" tabindex="-1"></a><span class="fu">### Asia/Pacific Innovations</span></span>
<span id="cb1-398"><a href="#cb1-398" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-399"><a href="#cb1-399" aria-hidden="true" tabindex="-1"></a>**Strengths:**</span>
<span id="cb1-400"><a href="#cb1-400" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-401"><a href="#cb1-401" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Strong PMDA regulatory focus</span>
<span id="cb1-402"><a href="#cb1-402" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Practical automation tools</span>
<span id="cb1-403"><a href="#cb1-403" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Under-represented population research</span>
<span id="cb1-404"><a href="#cb1-404" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Genetic diversity considerations</span>
<span id="cb1-405"><a href="#cb1-405" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-406"><a href="#cb1-406" aria-hidden="true" tabindex="-1"></a>**Notable Presentations:**</span>
<span id="cb1-407"><a href="#cb1-407" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-408"><a href="#cb1-408" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>SHIONOGI's open-source culture</span>
<span id="cb1-409"><a href="#cb1-409" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>{meRlin} AI assistant</span>
<span id="cb1-410"><a href="#cb1-410" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>PMDA e-CRT automation</span>
<span id="cb1-411"><a href="#cb1-411" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Vibe Coding approaches</span>
<span id="cb1-412"><a href="#cb1-412" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-413"><a href="#cb1-413" aria-hidden="true" tabindex="-1"></a><span class="fu">### Global Collaboration</span></span>
<span id="cb1-414"><a href="#cb1-414" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-415"><a href="#cb1-415" aria-hidden="true" tabindex="-1"></a>Conference demonstrated truly global R pharma community:</span>
<span id="cb1-416"><a href="#cb1-416" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-417"><a href="#cb1-417" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Workshops from US, Europe, Asia</span>
<span id="cb1-418"><a href="#cb1-418" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Shared challenges and solutions</span>
<span id="cb1-419"><a href="#cb1-419" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Pharmaverse as unifying force</span>
<span id="cb1-420"><a href="#cb1-420" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-421"><a href="#cb1-421" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-422"><a href="#cb1-422" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-423"><a href="#cb1-423" aria-hidden="true" tabindex="-1"></a><span class="fu">## 9. Future Directions üîÆ</span></span>
<span id="cb1-424"><a href="#cb1-424" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-425"><a href="#cb1-425" aria-hidden="true" tabindex="-1"></a><span class="fu">### Short-Term (2025-2026)</span></span>
<span id="cb1-426"><a href="#cb1-426" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-427"><a href="#cb1-427" aria-hidden="true" tabindex="-1"></a>**AI Integration:**</span>
<span id="cb1-428"><a href="#cb1-428" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-429"><a href="#cb1-429" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ More validated AI applications in production</span>
<span id="cb1-430"><a href="#cb1-430" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ MCP ecosystem expansion</span>
<span id="cb1-431"><a href="#cb1-431" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Regulatory guidance on AI in submissions</span>
<span id="cb1-432"><a href="#cb1-432" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Cost-effective on-premise LLM solutions</span>
<span id="cb1-433"><a href="#cb1-433" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-434"><a href="#cb1-434" aria-hidden="true" tabindex="-1"></a>**Automation:**</span>
<span id="cb1-435"><a href="#cb1-435" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-436"><a href="#cb1-436" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ ARS/ARM adoption across industry</span>
<span id="cb1-437"><a href="#cb1-437" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Push-button TFL generation becomes standard</span>
<span id="cb1-438"><a href="#cb1-438" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Automated slide decks and CSRs routine</span>
<span id="cb1-439"><a href="#cb1-439" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-440"><a href="#cb1-440" aria-hidden="true" tabindex="-1"></a>**Validation:**</span>
<span id="cb1-441"><a href="#cb1-441" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-442"><a href="#cb1-442" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Shared metric repositories operational</span>
<span id="cb1-443"><a href="#cb1-443" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Risk-based validation industry standard</span>
<span id="cb1-444"><a href="#cb1-444" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Shiny app validation frameworks mature</span>
<span id="cb1-445"><a href="#cb1-445" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-446"><a href="#cb1-446" aria-hidden="true" tabindex="-1"></a><span class="fu">### Medium-Term (2027-2028)</span></span>
<span id="cb1-447"><a href="#cb1-447" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-448"><a href="#cb1-448" aria-hidden="true" tabindex="-1"></a>**Tool Consolidation:**</span>
<span id="cb1-449"><a href="#cb1-449" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-450"><a href="#cb1-450" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Language-agnostic analysis platforms</span>
<span id="cb1-451"><a href="#cb1-451" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>R/Python/Julia interoperability</span>
<span id="cb1-452"><a href="#cb1-452" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Cloud-native pharma analytics</span>
<span id="cb1-453"><a href="#cb1-453" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-454"><a href="#cb1-454" aria-hidden="true" tabindex="-1"></a>**Regulatory:**</span>
<span id="cb1-455"><a href="#cb1-455" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-456"><a href="#cb1-456" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>AI-specific guidance documents</span>
<span id="cb1-457"><a href="#cb1-457" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Electronic submissions with code</span>
<span id="cb1-458"><a href="#cb1-458" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Real-time regulatory review platforms</span>
<span id="cb1-459"><a href="#cb1-459" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-460"><a href="#cb1-460" aria-hidden="true" tabindex="-1"></a>**Skills:**</span>
<span id="cb1-461"><a href="#cb1-461" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-462"><a href="#cb1-462" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>AI/LLM literacy standard for programmers</span>
<span id="cb1-463"><a href="#cb1-463" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Bayesian methods more accessible</span>
<span id="cb1-464"><a href="#cb1-464" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>DevOps practices ubiquitous</span>
<span id="cb1-465"><a href="#cb1-465" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-466"><a href="#cb1-466" aria-hidden="true" tabindex="-1"></a><span class="fu">### Long-Term (2029+)</span></span>
<span id="cb1-467"><a href="#cb1-467" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-468"><a href="#cb1-468" aria-hidden="true" tabindex="-1"></a>**Transformative Possibilities:**</span>
<span id="cb1-469"><a href="#cb1-469" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-470"><a href="#cb1-470" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**AI-Designed Clinical Trials**</span>
<span id="cb1-471"><a href="#cb1-471" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-472"><a href="#cb1-472" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>LLMs suggesting optimal designs</span>
<span id="cb1-473"><a href="#cb1-473" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Automated SAP generation</span>
<span id="cb1-474"><a href="#cb1-474" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Real-time adaptation</span>
<span id="cb1-475"><a href="#cb1-475" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-476"><a href="#cb1-476" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**Fully Automated TFLs**</span>
<span id="cb1-477"><a href="#cb1-477" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-478"><a href="#cb1-478" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>From data lock to submission package</span>
<span id="cb1-479"><a href="#cb1-479" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Human review only, no coding</span>
<span id="cb1-480"><a href="#cb1-480" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Multi-language outputs for global submissions</span>
<span id="cb1-481"><a href="#cb1-481" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-482"><a href="#cb1-482" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**Real-Time Safety Monitoring**</span>
<span id="cb1-483"><a href="#cb1-483" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-484"><a href="#cb1-484" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Continuous analysis during trials</span>
<span id="cb1-485"><a href="#cb1-485" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>AI-detected signals</span>
<span id="cb1-486"><a href="#cb1-486" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Predictive adverse event modeling</span>
<span id="cb1-487"><a href="#cb1-487" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-488"><a href="#cb1-488" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**Personalized Trial Design**</span>
<span id="cb1-489"><a href="#cb1-489" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-490"><a href="#cb1-490" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Bayesian adaptive with real-time learning</span>
<span id="cb1-491"><a href="#cb1-491" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Biomarker-driven enrollment</span>
<span id="cb1-492"><a href="#cb1-492" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Precision medicine integration</span>
<span id="cb1-493"><a href="#cb1-493" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-494"><a href="#cb1-494" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-495"><a href="#cb1-495" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-496"><a href="#cb1-496" aria-hidden="true" tabindex="-1"></a><span class="fu">## 10. Challenges &amp; Barriers ‚ö†Ô∏è</span></span>
<span id="cb1-497"><a href="#cb1-497" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-498"><a href="#cb1-498" aria-hidden="true" tabindex="-1"></a><span class="fu">### Technical Challenges</span></span>
<span id="cb1-499"><a href="#cb1-499" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-500"><a href="#cb1-500" aria-hidden="true" tabindex="-1"></a>**Validation Complexity:**</span>
<span id="cb1-501"><a href="#cb1-501" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-502"><a href="#cb1-502" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Non-deterministic AI outputs</span>
<span id="cb1-503"><a href="#cb1-503" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Rapidly evolving tools</span>
<span id="cb1-504"><a href="#cb1-504" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Keeping pace with innovation</span>
<span id="cb1-505"><a href="#cb1-505" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-506"><a href="#cb1-506" aria-hidden="true" tabindex="-1"></a>**Integration Issues:**</span>
<span id="cb1-507"><a href="#cb1-507" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-508"><a href="#cb1-508" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Legacy system compatibility</span>
<span id="cb1-509"><a href="#cb1-509" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Data silos</span>
<span id="cb1-510"><a href="#cb1-510" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>IT security constraints</span>
<span id="cb1-511"><a href="#cb1-511" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-512"><a href="#cb1-512" aria-hidden="true" tabindex="-1"></a><span class="fu">### Organizational Challenges</span></span>
<span id="cb1-513"><a href="#cb1-513" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-514"><a href="#cb1-514" aria-hidden="true" tabindex="-1"></a>**Cultural Resistance:**</span>
<span id="cb1-515"><a href="#cb1-515" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-516"><a href="#cb1-516" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>"SAS is what we've always used"</span>
<span id="cb1-517"><a href="#cb1-517" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Fear of change</span>
<span id="cb1-518"><a href="#cb1-518" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Risk aversion in regulated environment</span>
<span id="cb1-519"><a href="#cb1-519" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-520"><a href="#cb1-520" aria-hidden="true" tabindex="-1"></a>**Resource Constraints:**</span>
<span id="cb1-521"><a href="#cb1-521" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-522"><a href="#cb1-522" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Training investment required</span>
<span id="cb1-523"><a href="#cb1-523" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Dual maintenance (SAS + R) during transition</span>
<span id="cb1-524"><a href="#cb1-524" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Validation documentation burden</span>
<span id="cb1-525"><a href="#cb1-525" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-526"><a href="#cb1-526" aria-hidden="true" tabindex="-1"></a><span class="fu">### Regulatory Challenges</span></span>
<span id="cb1-527"><a href="#cb1-527" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-528"><a href="#cb1-528" aria-hidden="true" tabindex="-1"></a>**Uncertainty:**</span>
<span id="cb1-529"><a href="#cb1-529" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-530"><a href="#cb1-530" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Limited AI/LLM guidance</span>
<span id="cb1-531"><a href="#cb1-531" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Evolving expectations</span>
<span id="cb1-532"><a href="#cb1-532" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Regional variations (FDA vs EMA vs PMDA)</span>
<span id="cb1-533"><a href="#cb1-533" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-534"><a href="#cb1-534" aria-hidden="true" tabindex="-1"></a>**Documentation:**</span>
<span id="cb1-535"><a href="#cb1-535" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-536"><a href="#cb1-536" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>What level of detail for AI systems?</span>
<span id="cb1-537"><a href="#cb1-537" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>How to handle model updates?</span>
<span id="cb1-538"><a href="#cb1-538" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Third-party API dependencies</span>
<span id="cb1-539"><a href="#cb1-539" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-540"><a href="#cb1-540" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-541"><a href="#cb1-541" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-542"><a href="#cb1-542" aria-hidden="true" tabindex="-1"></a><span class="fu">## 11. Success Patterns üéØ</span></span>
<span id="cb1-543"><a href="#cb1-543" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-544"><a href="#cb1-544" aria-hidden="true" tabindex="-1"></a><span class="fu">### What Works</span></span>
<span id="cb1-545"><a href="#cb1-545" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-546"><a href="#cb1-546" aria-hidden="true" tabindex="-1"></a>Based on successful implementations presented:</span>
<span id="cb1-547"><a href="#cb1-547" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-548"><a href="#cb1-548" aria-hidden="true" tabindex="-1"></a>**1. Executive Sponsorship**</span>
<span id="cb1-549"><a href="#cb1-549" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-550"><a href="#cb1-550" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Clear targets (GSK's 50%)</span>
<span id="cb1-551"><a href="#cb1-551" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Resource commitment</span>
<span id="cb1-552"><a href="#cb1-552" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Long-term vision</span>
<span id="cb1-553"><a href="#cb1-553" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-554"><a href="#cb1-554" aria-hidden="true" tabindex="-1"></a>**2. Gradual Transformation**</span>
<span id="cb1-555"><a href="#cb1-555" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-556"><a href="#cb1-556" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Multi-wave approach</span>
<span id="cb1-557"><a href="#cb1-557" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Pilot programs</span>
<span id="cb1-558"><a href="#cb1-558" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Learn and adapt</span>
<span id="cb1-559"><a href="#cb1-559" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-560"><a href="#cb1-560" aria-hidden="true" tabindex="-1"></a>**3. Support Infrastructure**</span>
<span id="cb1-561"><a href="#cb1-561" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-562"><a href="#cb1-562" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Training programs (not just one-time)</span>
<span id="cb1-563"><a href="#cb1-563" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Help desks and office hours</span>
<span id="cb1-564"><a href="#cb1-564" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Documentation and resources</span>
<span id="cb1-565"><a href="#cb1-565" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-566"><a href="#cb1-566" aria-hidden="true" tabindex="-1"></a>**4. Community Building**</span>
<span id="cb1-567"><a href="#cb1-567" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-568"><a href="#cb1-568" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Internal R user groups</span>
<span id="cb1-569"><a href="#cb1-569" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>External pharmaverse participation</span>
<span id="cb1-570"><a href="#cb1-570" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Shared learning culture</span>
<span id="cb1-571"><a href="#cb1-571" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-572"><a href="#cb1-572" aria-hidden="true" tabindex="-1"></a>**5. Platform Investment**</span>
<span id="cb1-573"><a href="#cb1-573" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-574"><a href="#cb1-574" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Posit Workbench</span>
<span id="cb1-575"><a href="#cb1-575" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Version control (Git/GitHub)</span>
<span id="cb1-576"><a href="#cb1-576" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>CI/CD pipelines</span>
<span id="cb1-577"><a href="#cb1-577" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Cloud infrastructure</span>
<span id="cb1-578"><a href="#cb1-578" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-579"><a href="#cb1-579" aria-hidden="true" tabindex="-1"></a>**6. Standards Adoption**</span>
<span id="cb1-580"><a href="#cb1-580" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-581"><a href="#cb1-581" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>CDISC ARS/ARM</span>
<span id="cb1-582"><a href="#cb1-582" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Pharmaverse conventions</span>
<span id="cb1-583"><a href="#cb1-583" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Style guides and linters</span>
<span id="cb1-584"><a href="#cb1-584" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-585"><a href="#cb1-585" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-586"><a href="#cb1-586" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-587"><a href="#cb1-587" aria-hidden="true" tabindex="-1"></a><span class="fu">## 12. Actionable Insights üí°</span></span>
<span id="cb1-588"><a href="#cb1-588" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-589"><a href="#cb1-589" aria-hidden="true" tabindex="-1"></a><span class="fu">### For Organizations Starting R Adoption</span></span>
<span id="cb1-590"><a href="#cb1-590" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-591"><a href="#cb1-591" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**Start with low-risk projects** (exploratory analysis, visualizations)</span>
<span id="cb1-592"><a href="#cb1-592" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**Invest in training** early and continuously</span>
<span id="cb1-593"><a href="#cb1-593" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**Build internal community** (lunch &amp; learns, Slack channels)</span>
<span id="cb1-594"><a href="#cb1-594" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**Adopt pharmaverse packages** (don't reinvent)</span>
<span id="cb1-595"><a href="#cb1-595" aria-hidden="true" tabindex="-1"></a><span class="ss">5.  </span>**Establish validation framework** from day one</span>
<span id="cb1-596"><a href="#cb1-596" aria-hidden="true" tabindex="-1"></a><span class="ss">6.  </span>**Use Posit products** (Workbench, Connect, Package Manager)</span>
<span id="cb1-597"><a href="#cb1-597" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-598"><a href="#cb1-598" aria-hidden="true" tabindex="-1"></a><span class="fu">### For Organizations Scaling R</span></span>
<span id="cb1-599"><a href="#cb1-599" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-600"><a href="#cb1-600" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**Embrace automation** (ARS/ARM, template systems)</span>
<span id="cb1-601"><a href="#cb1-601" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**Implement CI/CD** for reproducibility</span>
<span id="cb1-602"><a href="#cb1-602" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**Explore AI carefully** (privacy first, validate thoroughly)</span>
<span id="cb1-603"><a href="#cb1-603" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**Contribute to pharmaverse** (share internal packages)</span>
<span id="cb1-604"><a href="#cb1-604" aria-hidden="true" tabindex="-1"></a><span class="ss">5.  </span>**Formalize support model** (beyond training)</span>
<span id="cb1-605"><a href="#cb1-605" aria-hidden="true" tabindex="-1"></a><span class="ss">6.  </span>**Plan SAS sunset** (don't maintain dual indefinitely)</span>
<span id="cb1-606"><a href="#cb1-606" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-607"><a href="#cb1-607" aria-hidden="true" tabindex="-1"></a><span class="fu">### For R Professionals</span></span>
<span id="cb1-608"><a href="#cb1-608" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-609"><a href="#cb1-609" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**Learn AI/LLM basics** (will be essential skill)</span>
<span id="cb1-610"><a href="#cb1-610" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**Master one reporting framework** (officer/flextable or Quarto)</span>
<span id="cb1-611"><a href="#cb1-611" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**Understand validation** (not just coding)</span>
<span id="cb1-612"><a href="#cb1-612" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**Contribute to open source** (career differentiator)</span>
<span id="cb1-613"><a href="#cb1-613" aria-hidden="true" tabindex="-1"></a><span class="ss">5.  </span>**Stay current** (R/Pharma, webinars, blogs)</span>
<span id="cb1-614"><a href="#cb1-614" aria-hidden="true" tabindex="-1"></a><span class="ss">6.  </span>**Network** (pharmaverse Slack, conferences)</span>
<span id="cb1-615"><a href="#cb1-615" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-616"><a href="#cb1-616" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-617"><a href="#cb1-617" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-618"><a href="#cb1-618" aria-hidden="true" tabindex="-1"></a><span class="fu">## 13. The Bigger Picture üåç</span></span>
<span id="cb1-619"><a href="#cb1-619" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-620"><a href="#cb1-620" aria-hidden="true" tabindex="-1"></a><span class="fu">### R/Pharma 2025 in Context</span></span>
<span id="cb1-621"><a href="#cb1-621" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-622"><a href="#cb1-622" aria-hidden="true" tabindex="-1"></a>This conference revealed an industry at an **inflection point**:</span>
<span id="cb1-623"><a href="#cb1-623" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-624"><a href="#cb1-624" aria-hidden="true" tabindex="-1"></a>**From:**</span>
<span id="cb1-625"><a href="#cb1-625" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-626"><a href="#cb1-626" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Proprietary, siloed tools</span>
<span id="cb1-627"><a href="#cb1-627" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Manual, repetitive coding</span>
<span id="cb1-628"><a href="#cb1-628" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Conservative, risk-averse culture</span>
<span id="cb1-629"><a href="#cb1-629" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Isolated company solutions</span>
<span id="cb1-630"><a href="#cb1-630" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-631"><a href="#cb1-631" aria-hidden="true" tabindex="-1"></a>**To:**</span>
<span id="cb1-632"><a href="#cb1-632" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-633"><a href="#cb1-633" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Open-source, collaborative development</span>
<span id="cb1-634"><a href="#cb1-634" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Automated, standards-driven workflows</span>
<span id="cb1-635"><a href="#cb1-635" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Innovative, evidence-based adoption</span>
<span id="cb1-636"><a href="#cb1-636" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Shared industry platforms</span>
<span id="cb1-637"><a href="#cb1-637" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-638"><a href="#cb1-638" aria-hidden="true" tabindex="-1"></a><span class="fu">### Why This Matters</span></span>
<span id="cb1-639"><a href="#cb1-639" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-640"><a href="#cb1-640" aria-hidden="true" tabindex="-1"></a>**For Patients:**</span>
<span id="cb1-641"><a href="#cb1-641" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-642"><a href="#cb1-642" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Faster drug development</span>
<span id="cb1-643"><a href="#cb1-643" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>More rigorous analysis</span>
<span id="cb1-644"><a href="#cb1-644" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Transparent, reproducible science</span>
<span id="cb1-645"><a href="#cb1-645" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Precision medicine enablement</span>
<span id="cb1-646"><a href="#cb1-646" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-647"><a href="#cb1-647" aria-hidden="true" tabindex="-1"></a>**For Industry:**</span>
<span id="cb1-648"><a href="#cb1-648" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-649"><a href="#cb1-649" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Reduced costs</span>
<span id="cb1-650"><a href="#cb1-650" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Faster time to market</span>
<span id="cb1-651"><a href="#cb1-651" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Better talent recruitment</span>
<span id="cb1-652"><a href="#cb1-652" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Competitive advantage</span>
<span id="cb1-653"><a href="#cb1-653" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-654"><a href="#cb1-654" aria-hidden="true" tabindex="-1"></a>**For Science:**</span>
<span id="cb1-655"><a href="#cb1-655" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-656"><a href="#cb1-656" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Reproducibility crisis addressed</span>
<span id="cb1-657"><a href="#cb1-657" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Method innovation accelerated</span>
<span id="cb1-658"><a href="#cb1-658" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Global collaboration enabled</span>
<span id="cb1-659"><a href="#cb1-659" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Democratized advanced analytics</span>
<span id="cb1-660"><a href="#cb1-660" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-661"><a href="#cb1-661" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-662"><a href="#cb1-662" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-663"><a href="#cb1-663" aria-hidden="true" tabindex="-1"></a><span class="fu">## 14. How R/Pharma Has Evolved üìà</span></span>
<span id="cb1-664"><a href="#cb1-664" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-665"><a href="#cb1-665" aria-hidden="true" tabindex="-1"></a><span class="fu">### Conference Evolution (2018-2025)</span></span>
<span id="cb1-666"><a href="#cb1-666" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-667"><a href="#cb1-667" aria-hidden="true" tabindex="-1"></a>Based on publicly available information and this year's content, here's how the conference themes have shifted:</span>
<span id="cb1-668"><a href="#cb1-668" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-669"><a href="#cb1-669" aria-hidden="true" tabindex="-1"></a><span class="fu">#### **2018-2020: Foundation Years**</span></span>
<span id="cb1-670"><a href="#cb1-670" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-671"><a href="#cb1-671" aria-hidden="true" tabindex="-1"></a>**Key Themes:**</span>
<span id="cb1-672"><a href="#cb1-672" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-673"><a href="#cb1-673" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üì¶ **Package development basics** - Building pharma packages</span>
<span id="cb1-674"><a href="#cb1-674" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üìä **Basic Shiny apps** - Interactive visualizations</span>
<span id="cb1-675"><a href="#cb1-675" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üîÑ **SAS vs R debates** - "Should we switch?"</span>
<span id="cb1-676"><a href="#cb1-676" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üìù **Simple reporting** - Basic TFLs</span>
<span id="cb1-677"><a href="#cb1-677" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-678"><a href="#cb1-678" aria-hidden="true" tabindex="-1"></a>**Sentiment:** Cautious optimism, early adopters sharing success stories</span>
<span id="cb1-679"><a href="#cb1-679" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-680"><a href="#cb1-680" aria-hidden="true" tabindex="-1"></a>**Notable:**</span>
<span id="cb1-681"><a href="#cb1-681" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-682"><a href="#cb1-682" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Pharmaverse not yet established</span>
<span id="cb1-683"><a href="#cb1-683" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Validation was major concern</span>
<span id="cb1-684"><a href="#cb1-684" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>FDA software neutrality clarification (2015) still fresh</span>
<span id="cb1-685"><a href="#cb1-685" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-686"><a href="#cb1-686" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-687"><a href="#cb1-687" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-688"><a href="#cb1-688" aria-hidden="true" tabindex="-1"></a><span class="fu">#### **2021-2022: Acceleration Phase**</span></span>
<span id="cb1-689"><a href="#cb1-689" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-690"><a href="#cb1-690" aria-hidden="true" tabindex="-1"></a>**Key Themes:**</span>
<span id="cb1-691"><a href="#cb1-691" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-692"><a href="#cb1-692" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üöÄ **COVID acceleration** - Remote work drove R adoption</span>
<span id="cb1-693"><a href="#cb1-693" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>ü§ù **Pharmaverse launch** - Collaborative ecosystem born</span>
<span id="cb1-694"><a href="#cb1-694" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ **Validation frameworks** - {riskmetric}, R Validation Hub</span>
<span id="cb1-695"><a href="#cb1-695" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üì¶ **Production packages** - {admiral}, {teal} gaining traction</span>
<span id="cb1-696"><a href="#cb1-696" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-697"><a href="#cb1-697" aria-hidden="true" tabindex="-1"></a>**Sentiment:** Growing confidence, momentum building</span>
<span id="cb1-698"><a href="#cb1-698" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-699"><a href="#cb1-699" aria-hidden="true" tabindex="-1"></a>**Milestones:**</span>
<span id="cb1-700"><a href="#cb1-700" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-701"><a href="#cb1-701" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Major pharma (Roche, Novartis) sharing production solutions</span>
<span id="cb1-702"><a href="#cb1-702" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Regulatory submissions with R increasing</span>
<span id="cb1-703"><a href="#cb1-703" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Training programs formalized (GSK example)</span>
<span id="cb1-704"><a href="#cb1-704" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-705"><a href="#cb1-705" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-706"><a href="#cb1-706" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-707"><a href="#cb1-707" aria-hidden="true" tabindex="-1"></a><span class="fu">#### **2023-2024: Mainstream Adoption**</span></span>
<span id="cb1-708"><a href="#cb1-708" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-709"><a href="#cb1-709" aria-hidden="true" tabindex="-1"></a>**Key Themes:**</span>
<span id="cb1-710"><a href="#cb1-710" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-711"><a href="#cb1-711" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üìä **CDISC integration** - Analysis Results Standard (ARS/ARM)</span>
<span id="cb1-712"><a href="#cb1-712" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üîß **Automation focus** - Template-based TFL generation</span>
<span id="cb1-713"><a href="#cb1-713" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üìà **Advanced analytics** - Bayesian methods, ML</span>
<span id="cb1-714"><a href="#cb1-714" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üåê **Multi-language** - R + Python workflows</span>
<span id="cb1-715"><a href="#cb1-715" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-716"><a href="#cb1-716" aria-hidden="true" tabindex="-1"></a>**Sentiment:** R is mainstream, focus shifts to optimization</span>
<span id="cb1-717"><a href="#cb1-717" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-718"><a href="#cb1-718" aria-hidden="true" tabindex="-1"></a>**Evidence:**</span>
<span id="cb1-719"><a href="#cb1-719" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-720"><a href="#cb1-720" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Multiple talks on automation (not just feasibility)</span>
<span id="cb1-721"><a href="#cb1-721" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Validation becoming standardized, less controversial</span>
<span id="cb1-722"><a href="#cb1-722" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Advanced topics (multistate models, Stan) gaining space</span>
<span id="cb1-723"><a href="#cb1-723" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-724"><a href="#cb1-724" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-725"><a href="#cb1-725" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-726"><a href="#cb1-726" aria-hidden="true" tabindex="-1"></a><span class="fu">#### **2025: AI Revolution Year**</span></span>
<span id="cb1-727"><a href="#cb1-727" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-728"><a href="#cb1-728" aria-hidden="true" tabindex="-1"></a>**Dominant Themes:**</span>
<span id="cb1-729"><a href="#cb1-729" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-730"><a href="#cb1-730" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>ü§ñ **AI/LLM explosion** - 8+ sessions (50% increase)</span>
<span id="cb1-731"><a href="#cb1-731" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üè¢ **Enterprise transformation** - GSK's 50%+ achievement</span>
<span id="cb1-732"><a href="#cb1-732" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ **Regulatory maturity** - GxP-ready AI, validated Shiny</span>
<span id="cb1-733"><a href="#cb1-733" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>üöÄ **Production at scale** - From "can we?" to "how fast?"</span>
<span id="cb1-734"><a href="#cb1-734" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-735"><a href="#cb1-735" aria-hidden="true" tabindex="-1"></a>**Shift in Discourse:**</span>
<span id="cb1-736"><a href="#cb1-736" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-737"><a href="#cb1-737" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**2018:** "Is R viable for pharma?"</span>
<span id="cb1-738"><a href="#cb1-738" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**2022:** "How do we migrate from SAS?"</span>
<span id="cb1-739"><a href="#cb1-739" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**2025:** "How do we integrate AI with R?"</span>
<span id="cb1-740"><a href="#cb1-740" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-741"><a href="#cb1-741" aria-hidden="true" tabindex="-1"></a>**What's New in 2025:**</span>
<span id="cb1-742"><a href="#cb1-742" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-743"><a href="#cb1-743" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**AI Dominance**</span>
<span id="cb1-744"><a href="#cb1-744" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-745"><a href="#cb1-745" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2018-2022: Barely mentioned</span>
<span id="cb1-746"><a href="#cb1-746" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2023: Experimental projects</span>
<span id="cb1-747"><a href="#cb1-747" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2024: Pilot implementations</span>
<span id="cb1-748"><a href="#cb1-748" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>**2025: Production systems** ({llumen}, multi-agent copilots, enterprise frameworks)</span>
<span id="cb1-749"><a href="#cb1-749" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-750"><a href="#cb1-750" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**Regulatory Confidence**</span>
<span id="cb1-751"><a href="#cb1-751" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-752"><a href="#cb1-752" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2018-2020: "Will FDA accept this?"</span>
<span id="cb1-753"><a href="#cb1-753" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2021-2022: "Here's how we validated"</span>
<span id="cb1-754"><a href="#cb1-754" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2023-2024: "Validation frameworks established"</span>
<span id="cb1-755"><a href="#cb1-755" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>**2025: "Validated AI in GxP"** - previously unthinkable</span>
<span id="cb1-756"><a href="#cb1-756" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-757"><a href="#cb1-757" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**Speed of Innovation**</span>
<span id="cb1-758"><a href="#cb1-758" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-759"><a href="#cb1-759" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2018: Yearly package updates</span>
<span id="cb1-760"><a href="#cb1-760" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2022: Quarterly releases (pharmaverse)</span>
<span id="cb1-761"><a href="#cb1-761" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>**2025: Real-time AI integration** - tools released months ago</span>
<span id="cb1-762"><a href="#cb1-762" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-763"><a href="#cb1-763" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**Collaboration Level**</span>
<span id="cb1-764"><a href="#cb1-764" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-765"><a href="#cb1-765" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2018: Individual company solutions</span>
<span id="cb1-766"><a href="#cb1-766" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2020: Pharmaverse begins</span>
<span id="cb1-767"><a href="#cb1-767" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>2023: Cross-company working groups</span>
<span id="cb1-768"><a href="#cb1-768" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>**2025: Shared AI infrastructure** (MCP, metric repos)</span>
<span id="cb1-769"><a href="#cb1-769" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-770"><a href="#cb1-770" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-771"><a href="#cb1-771" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-772"><a href="#cb1-772" aria-hidden="true" tabindex="-1"></a><span class="fu">### Topic Frequency Evolution</span></span>
<span id="cb1-773"><a href="#cb1-773" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-774"><a href="#cb1-774" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> Topic                   <span class="pp">|</span> 2020   <span class="pp">|</span> 2022   <span class="pp">|</span> 2024   <span class="pp">|</span> **2025**     <span class="pp">|</span></span>
<span id="cb1-775"><a href="#cb1-775" aria-hidden="true" tabindex="-1"></a><span class="pp">|-------------------------|--------|--------|--------|--------------|</span></span>
<span id="cb1-776"><a href="#cb1-776" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> **Package Development** <span class="pp">|</span> üî•üî•üî• <span class="pp">|</span> üî•üî•   <span class="pp">|</span> üî•     <span class="pp">|</span> üî•           <span class="pp">|</span></span>
<span id="cb1-777"><a href="#cb1-777" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> **Validation**          <span class="pp">|</span> üî•üî•üî• <span class="pp">|</span> üî•üî•üî• <span class="pp">|</span> üî•üî•   <span class="pp">|</span> üî•           <span class="pp">|</span></span>
<span id="cb1-778"><a href="#cb1-778" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> **Shiny Apps**          <span class="pp">|</span> üî•üî•   <span class="pp">|</span> üî•üî•üî• <span class="pp">|</span> üî•üî•   <span class="pp">|</span> üî•üî•         <span class="pp">|</span></span>
<span id="cb1-779"><a href="#cb1-779" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> **Clinical Reporting**  <span class="pp">|</span> üî•üî•   <span class="pp">|</span> üî•üî•   <span class="pp">|</span> üî•üî•üî• <span class="pp">|</span> üî•üî•üî•       <span class="pp">|</span></span>
<span id="cb1-780"><a href="#cb1-780" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> **Bayesian Methods**    <span class="pp">|</span> üî•     <span class="pp">|</span> üî•     <span class="pp">|</span> üî•üî•   <span class="pp">|</span> üî•üî•         <span class="pp">|</span></span>
<span id="cb1-781"><a href="#cb1-781" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> **AI/LLM**              | \-     | \-     | üî•     | **üî•üî•üî•üî•** <span class="pp">|</span></span>
<span id="cb1-782"><a href="#cb1-782" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> **Automation**          | üî•     | üî•üî•   | üî•üî•   | **üî•üî•üî•**   <span class="pp">|</span></span>
<span id="cb1-783"><a href="#cb1-783" aria-hidden="true" tabindex="-1"></a><span class="pp">|</span> **Python Integration**  | üî•     | üî•     | üî•üî•   | **üî•üî•**     <span class="pp">|</span></span>
<span id="cb1-784"><a href="#cb1-784" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-785"><a href="#cb1-785" aria-hidden="true" tabindex="-1"></a>**Interpretation:**</span>
<span id="cb1-786"><a href="#cb1-786" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-787"><a href="#cb1-787" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Traditional topics (package dev, validation) declining as they become **solved problems**</span>
<span id="cb1-788"><a href="#cb1-788" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>AI/LLM emerged from nowhere to **dominate** the conversation</span>
<span id="cb1-789"><a href="#cb1-789" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Automation shifted from "nice to have" to **strategic imperative**</span>
<span id="cb1-790"><a href="#cb1-790" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Python integration normalized (not R vs Python, but R **and** Python)</span>
<span id="cb1-791"><a href="#cb1-791" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-792"><a href="#cb1-792" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-793"><a href="#cb1-793" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-794"><a href="#cb1-794" aria-hidden="true" tabindex="-1"></a><span class="fu">### What Changed Between 2024 and 2025?</span></span>
<span id="cb1-795"><a href="#cb1-795" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-796"><a href="#cb1-796" aria-hidden="true" tabindex="-1"></a>**Major Shifts:**</span>
<span id="cb1-797"><a href="#cb1-797" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-798"><a href="#cb1-798" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**{ellmer} Package Launch** (2024)</span>
<span id="cb1-799"><a href="#cb1-799" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-800"><a href="#cb1-800" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Made LLM integration trivial in R</span>
<span id="cb1-801"><a href="#cb1-801" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Multiple workshops/presentations built on it</span>
<span id="cb1-802"><a href="#cb1-802" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Enterprise adoption accelerated</span>
<span id="cb1-803"><a href="#cb1-803" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-804"><a href="#cb1-804" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**Claude/ChatGPT API Maturity**</span>
<span id="cb1-805"><a href="#cb1-805" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-806"><a href="#cb1-806" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Function calling standardized</span>
<span id="cb1-807"><a href="#cb1-807" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>MCP protocol emerged</span>
<span id="cb1-808"><a href="#cb1-808" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Privacy-preserving deployments viable</span>
<span id="cb1-809"><a href="#cb1-809" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-810"><a href="#cb1-810" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**GSK Milestone**</span>
<span id="cb1-811"><a href="#cb1-811" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-812"><a href="#cb1-812" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>50%+ R code achieved</span>
<span id="cb1-813"><a href="#cb1-813" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Proof that full transformation possible</span>
<span id="cb1-814"><a href="#cb1-814" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Other pharma following suit</span>
<span id="cb1-815"><a href="#cb1-815" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-816"><a href="#cb1-816" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**CDISC ARS Adoption**</span>
<span id="cb1-817"><a href="#cb1-817" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-818"><a href="#cb1-818" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Analysis Results Standard gaining traction</span>
<span id="cb1-819"><a href="#cb1-819" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Mosaic (Novartis) and others automating TFLs</span>
<span id="cb1-820"><a href="#cb1-820" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Machine-readable results enabling AI</span>
<span id="cb1-821"><a href="#cb1-821" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-822"><a href="#cb1-822" aria-hidden="true" tabindex="-1"></a><span class="ss">5.  </span>**Posit Product Evolution**</span>
<span id="cb1-823"><a href="#cb1-823" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-824"><a href="#cb1-824" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Positron IDE launched (VS Code + R)</span>
<span id="cb1-825"><a href="#cb1-825" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>Better Python support</span>
<span id="cb1-826"><a href="#cb1-826" aria-hidden="true" tabindex="-1"></a><span class="ss">    -   </span>AI assistants integrated</span>
<span id="cb1-827"><a href="#cb1-827" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-828"><a href="#cb1-828" aria-hidden="true" tabindex="-1"></a>**What Stayed Constant:**</span>
<span id="cb1-829"><a href="#cb1-829" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-830"><a href="#cb1-830" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Pharmaverse continues thriving</span>
<span id="cb1-831"><a href="#cb1-831" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Validation remains priority (but less controversial)</span>
<span id="cb1-832"><a href="#cb1-832" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Collaboration over competition</span>
<span id="cb1-833"><a href="#cb1-833" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Open-source commitment</span>
<span id="cb1-834"><a href="#cb1-834" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-835"><a href="#cb1-835" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-836"><a href="#cb1-836" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-837"><a href="#cb1-837" aria-hidden="true" tabindex="-1"></a><span class="fu">### Predictions for R/Pharma 2026</span></span>
<span id="cb1-838"><a href="#cb1-838" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-839"><a href="#cb1-839" aria-hidden="true" tabindex="-1"></a>Based on the trajectory, expect:</span>
<span id="cb1-840"><a href="#cb1-840" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-841"><a href="#cb1-841" aria-hidden="true" tabindex="-1"></a>**Likely Topics:**</span>
<span id="cb1-842"><a href="#cb1-842" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-843"><a href="#cb1-843" aria-hidden="true" tabindex="-1"></a><span class="ss">1.  </span>**"AI in Submissions"** - First AI-powered analysis in regulatory filing</span>
<span id="cb1-844"><a href="#cb1-844" aria-hidden="true" tabindex="-1"></a><span class="ss">2.  </span>**"Real-time Clinical Trial Analysis"** - Adaptive designs with AI</span>
<span id="cb1-845"><a href="#cb1-845" aria-hidden="true" tabindex="-1"></a><span class="ss">3.  </span>**"Synthetic Patient Generation"** - Privacy-preserving AI for trials</span>
<span id="cb1-846"><a href="#cb1-846" aria-hidden="true" tabindex="-1"></a><span class="ss">4.  </span>**"Quantum ML for Drug Discovery"** - Cutting edge</span>
<span id="cb1-847"><a href="#cb1-847" aria-hidden="true" tabindex="-1"></a><span class="ss">5.  </span>**"Fully Automated Study Reports"** - From data lock to CSR in hours</span>
<span id="cb1-848"><a href="#cb1-848" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-849"><a href="#cb1-849" aria-hidden="true" tabindex="-1"></a>**Maturing Topics:**</span>
<span id="cb1-850"><a href="#cb1-850" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-851"><a href="#cb1-851" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>LLM integration will be **assumed** (not taught from scratch)</span>
<span id="cb1-852"><a href="#cb1-852" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Validation frameworks **standardized** across industry</span>
<span id="cb1-853"><a href="#cb1-853" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>Python-R **seamless** interop (not separate tracks)</span>
<span id="cb1-854"><a href="#cb1-854" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-855"><a href="#cb1-855" aria-hidden="true" tabindex="-1"></a>**Declining Topics:**</span>
<span id="cb1-856"><a href="#cb1-856" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-857"><a href="#cb1-857" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>"Intro to R packages" (basics widely known)</span>
<span id="cb1-858"><a href="#cb1-858" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>"Why leave SAS?" (decision already made)</span>
<span id="cb1-859"><a href="#cb1-859" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>"Can we validate R?" (settled question)</span>
<span id="cb1-860"><a href="#cb1-860" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-861"><a href="#cb1-861" aria-hidden="true" tabindex="-1"></a>**Bold Prediction:**</span>
<span id="cb1-862"><a href="#cb1-862" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-863"><a href="#cb1-863" aria-hidden="true" tabindex="-1"></a>R/Pharma 2026 will feature the **first fully AI-generated clinical study report** accepted by a regulatory agency. The discussion will shift from "Is this possible?" to "What should humans still review?"</span>
<span id="cb1-864"><a href="#cb1-864" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-865"><a href="#cb1-865" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-866"><a href="#cb1-866" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-867"><a href="#cb1-867" aria-hidden="true" tabindex="-1"></a><span class="fu">## 15. Conclusion</span></span>
<span id="cb1-868"><a href="#cb1-868" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-869"><a href="#cb1-869" aria-hidden="true" tabindex="-1"></a>R/Pharma 2025 demonstrated that open-source pharmaceutical analytics is not the future **it's the present**. With AI integration, regulatory acceptance, and enterprise adoption converging, the question is no longer "Should we adopt R?" but "How fast can we transform?"</span>
<span id="cb1-870"><a href="#cb1-870" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-871"><a href="#cb1-871" aria-hidden="true" tabindex="-1"></a>The conference showcased:</span>
<span id="cb1-872"><a href="#cb1-872" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-873"><a href="#cb1-873" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Production-ready AI systems</span>
<span id="cb1-874"><a href="#cb1-874" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Validated, GxP-compliant workflows</span>
<span id="cb1-875"><a href="#cb1-875" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Major pharma success stories (GSK 50%+)</span>
<span id="cb1-876"><a href="#cb1-876" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Thriving ecosystem (pharmaverse)</span>
<span id="cb1-877"><a href="#cb1-877" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>‚úÖ Regulatory confidence (FDA neutrality)</span>
<span id="cb1-878"><a href="#cb1-878" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-879"><a href="#cb1-879" aria-hidden="true" tabindex="-1"></a>**The momentum is undeniable. The future is open source. The time is now.**</span>
<span id="cb1-880"><a href="#cb1-880" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-881"><a href="#cb1-881" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-882"><a href="#cb1-882" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-883"><a href="#cb1-883" aria-hidden="true" tabindex="-1"></a>::: callout-tip</span>
<span id="cb1-884"><a href="#cb1-884" aria-hidden="true" tabindex="-1"></a><span class="fu">## Stay Connected</span></span>
<span id="cb1-885"><a href="#cb1-885" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-886"><a href="#cb1-886" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**R/Pharma website:** <span class="co">[</span><span class="ot">rinpharma.com</span><span class="co">](https://rinpharma.com)</span></span>
<span id="cb1-887"><a href="#cb1-887" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Pharmaverse:** <span class="co">[</span><span class="ot">pharmaverse.org</span><span class="co">](https://pharmaverse.org)</span></span>
<span id="cb1-888"><a href="#cb1-888" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**Posit:** <span class="co">[</span><span class="ot">posit.co</span><span class="co">](https://posit.co)</span></span>
<span id="cb1-889"><a href="#cb1-889" aria-hidden="true" tabindex="-1"></a><span class="ss">-   </span>**R Validation Hub:** <span class="co">[</span><span class="ot">pharmar.org</span><span class="co">](https://www.pharmar.org)</span></span>
<span id="cb1-890"><a href="#cb1-890" aria-hidden="true" tabindex="-1"></a>:::</span>
<span id="cb1-891"><a href="#cb1-891" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-892"><a href="#cb1-892" aria-hidden="true" tabindex="-1"></a>------------------------------------------------------------------------</span>
<span id="cb1-893"><a href="#cb1-893" aria-hidden="true" tabindex="-1"></a></span>
<span id="cb1-894"><a href="#cb1-894" aria-hidden="true" tabindex="-1"></a>*Analysis compiled from R/Pharma 2025 Conference materials \| Last updated: November 2025*</span></code></pre></div><button title="Copy to Clipboard" class="code-copy-button" data-in-quarto-modal=""><i class="bi"></i></button></div>
</div></div></div></div></div>
</div> <!-- /content -->
<footer class="footer">
  <div class="nav-footer">
    <div class="nav-footer-left">
<p>¬© 2025 <a href="https://www.linkedin.com/in/myrta/">Szymon Myrta</a> | <a href="about.qmd#rpharma-2025-workshop-certificates">üéì 11 R/Pharma Workshop Certificates</a></p>
</div>   
    <div class="nav-footer-center">
      &nbsp;
    </div>
    <div class="nav-footer-right">
      <ul class="footer-items list-unstyled">
    <li class="nav-item compact">
    <a class="nav-link" href="https://www.linkedin.com/in/myrta/">
      <i class="bi bi-linkedin" role="img">
</i> 
    </a>
  </li>  
    <li class="nav-item compact">
    <a class="nav-link" href="https://github.com/ACTN3">
      <i class="bi bi-github" role="img">
</i> 
    </a>
  </li>  
    <li class="nav-item">
    <a class="nav-link" href="https://orcid.org/0000-0003-1714-6105">
<p>{{ORCID}}</p>
</a>
  </li>  
</ul>
    </div>
  </div>
</footer>




<script src="../site_libs/quarto-html/zenscroll-min.js"></script>
</body></html>